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Abstract  
The Escherichia coli F plasmid is representative of conjugative type IV secretion system 
for the transmission of mobile DNA elements in bacteria, a contributor to widespread antibiotic 
resistance.  The TraG protein of this system consists of a membrane-bound N-terminal domain and 
a periplasmic C-terminal domain, denoted TraG*. TraG* is essential in preventing redundant DNA 
transfer. In the donor cell it interacts with TraN within the outer membrane to facilitate mating pair 
stabilisation. However, TraG* also interacts with a cognate TraS in the inner membrane of the 
recipient cell to prevent conjugation when the recipient cell carries the same plasmid. This thesis 
presents structural studies of TraG*; Thermofluor, circular dichroism and HDX-MS experiments 
showed N-terminal truncation mutants displayed higher stability and less disordered content 
relative to full-length TraG*. The 45 N-terminal residues of TraG* were predicted to be highly 
dynamic, possibly serving as a flexible linker between two independently functioning domains.  
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CHAPTER 1.0 ‒ INTRODUCTION 
1.1 The Mounting Threat of Bacterial Antibiotic Resistance as Aided by Horizontal Gene 
Transfer  
Multidrug-resistant (MDR) bacterial pathogens; classified as strains that exhibit a 
phenotype with resistance to three or more antibiotic classes, are a substantial threat to public 
health as the number of accessible antibiotics that can efficiently eliminate infections of MDR 
species are perilously limited (Thomson and Bonomo, 2005). Increasing numbers of these species 
have been observed globally, largely aided by poor nosocomial hygiene, excessive use of 
antibiotics in animal agriculture, and over-prescription of broad spectrum antibiotics (Chang et al., 
2015; Pelat et al., 2015). As well, it is estimated that 23,000 deaths in the U.S.A. alone are 
attributed to infections by MDR bacteria annually (Chang et al., 2015).   
Genes conferring antibiotic resistance are evolved and persist as a result of selective 
pressures in bacterial populations; rapid cellular reproduction and the plasticity of the bacterial 
genome allows for their propagation through colonies of these pathogens by methods of DNA 
replication such as binary fission and methods of DNA transmission through horizontal gene 
transfer (HGT) (Allen et al., 2010). HGT allows for the accelerated dissemination of advantageous 
genes independent of the speed of replication. Beneficial genes would include those that code for 
drug efflux pumps, antibiotic inactivating enzymes, altered drug targets and many other virulence 
factors (Figure 1.1) (Sultan et al., 2018). HGT methods include transformation through the import 
of extracellular DNA, viral transduction through the successful entry and recombination of 
bacteriophage-packaged genes, and conjugation (Gogarten and Townsend, 2005; Gyles and 
Boerlin, 2014). Genes are transferred by bacteria in a donor-controlled fashion using conjugation, 
in which mobile genetic elements such as plasmids or chromosomally integrated conjugative 
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elements (ICEs) are replicated in a donor cell and transported into a recipient cell using a Type IV 
secretion system (T4SS) (Bennett, 2008). As conjugation systems are ubiquitous in the bacterial 
kingdom, inhibition of plasmid conjugation has been suggested as a tool to prevent the spread of 
antibiotic resistance genes, thus preventing the proliferation of MDR pathogens (Baron, 2013, 
2010; Williams and Hergenrother, 2008).  
  
 
Figure 1.1: Common mechanisms of acquiring and transmitting genetic material in bacterial 
species and examples of the encoded functions of these genes. The resistance mechanisms shown 
above include modifications of the bacterial envelope components to alter permeability of drugs, 
substrate efflux pumps, enzymes that modify and inactivate antimicrobial molecules, and the 
production of an altered homologue of a drug target (Sultan et al., 2018). The acquisition of these 
genes occurs through either mutation or HGT methods such as the transformation of extracellular 
DNA, transduction of viral DNA and integration into the bacterial chromosome, and conjugative 
transfer of a plasmid through a pilus (Gogarten and Townsend, 2005; Gyles and Boerlin, 2014). 
This transfer of DNA through the pilus is a common model for conjugation by the T4SS (Costa et 
al., 2016). Image adapted from (Sultan et al., 2018).    
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1.2 Evidence for Urgency in Studying Gram-Negative Bacteria   
 Gram-negative bacteria differ from gram positive bacteria in the composition of their cell 
wall; the classification of species into these groups is classically based on Gram Staining 
techniques through the binding of peptidoglycan by hexamethyl pararosaniline chloride (crystal 
violet) (Gregersen, 1978). The bacterial envelope of gram-negative species consists of an outer 
lipid bilayer with bound lipopolysaccharides (LPS), a periplasm consisting of peptidoglycan, and 
an inner cytoplasmic membrane (IM). Gram positive species lack an outer membrane (OM); 
instead they feature a cell wall composed of peptidoglycan with lipoteichoic acid and a cytoplasmic 
lipid membrane. The presence of an OM provides gram-negative species with an added 
permeability barrier relative to gram positive bacteria, resulting in differences in the penetration 
and retention of molecules (Grohmann et al., 2003). This provides gram-negative bacteria a degree 
of intrinsic antibiotic resistance, as some drugs and antibiotics effective against gram positive 
bacteria cannot permeate the OM of gram-negative species.  
 There are a number of medically relevant gram-negative bacterial species proving to be 
hazards to public health, including Acinetobacter spp., Campylobacter spp., Helicobacter pylori, 
Haemophilus influenzae, Pseudomonas aeruginosa and a number of Enterobacteriaceae spp. 
(Exner et al., 2017; Lerminiaux and Cameron, 2018). All of these species and more have been 
found as MDR strains resistant against ureidopenicillins, third or fourth generation cephalosporins, 
carbapenems, fluoroquinolones, and other antibiotics normally effective to these species (Exner et 
al., 2017).  As these antibiotics, in particular carbapenems, are typically used as the last line of 
effective treatment for infections with multidrug resistant gram-negative species, the emergence 
of human pathogens resistant to them has been deemed a critical clinical issue by the World Health 
Organization (WHO) (Exner et al., 2017; Lerminiaux and Cameron, 2018). Exasperating the 
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situation, the mobile gene mcr-1 has been reported in microbiota of farm animals from China, the 
U.K., Denmark, the U.S. and Germany (Exner et al., 2017). This gene provides resistance against 
the polypeptide colistin, a reserve antibiotic for the treatment of critically ill patients in instances 
of infection by carbapenem MDR gram-negative bacteria; novel antibiotics are desperately 
needed.  
Many efforts have been made in combatting MDR gram positive bacteria; novel 
antimicrobial agents and antibiotics from new classes have been developed to target these species 
(Giske et al., 2008). However less progress has been made in the development of novel drugs 
effective in targeting MDR gram-negative pathogens. Therefore, there is a vital need for further 
research into the modes of antibiotic resistance in gram-negative bacteria or humanity will regress 
to a state mirroring that of pre-antibiotic eras. 
        
1.3 Gram-Negative Bacterial Conjugation by T4SS 
1.3.1 The Utility of Conjugative T4SS 
Conjugation in gram-negative bacteria is enabled by T4SS; large multi-protein complexes 
that span inner and outer cellular membranes and are the most ubiquitous secretion system in 
nature (Costa et al., 2015). Their prevalence throughout the bacterial kingdom is due to the 
evolution of the conjugal T4SS in a common ancestor; natural selection has favoured conjugation, 
as donor-mediated HGT appears to be a necessity for survival based on the requirement for rapid 
evolution in the competitive environment of unicellular organisms (Vogan and Higgs, 2011). As 
well, conjugation has been observed to occur between bacterial species to transmit plasmids with 
beneficial genes across broad host ranges (Grohmann et al., 2003; Lerminiaux and Cameron, 
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2018). As conjugation is arguably the most common method by which antibiotic resistance genes 
are transmitted, a thorough understanding of the conjugation process is paramount in the 
development of novel drugs to target the T4SS and prevent dissemination of antibiotic resistance 
(Cabezón et al., 2017; Lujan et al., 2007; Waksman, 2019). 
    
1.3.2 Initiation of Conjugation, Pilus Assembly and Extension 
As the conjugative transfer of DNA is a metabolically costly process for bacterial cells, the 
activation of T4SSs are strictly regulated (Koraimann and Wagner, 2014). In the production of 
conjugative systems, gene expression is limited by one or both of the following mechanisms: 
signalling molecules (autoinducers or sex pheromones), and low constitutive gene expression  
(Kohler et al., 2019). The regulation of conjugation in plasmids from the IncF inclusion family 
occurs solely by the latter process and was termed fertility inhibition (fin) (Koraimann et al., 1996). 
The gene coding for the activator of the transfer (tra) operon expression, traJ, is controlled by 
finOP regulatory genes. The downregulation of TraJ expression is controlled by the antisense RNA 
FinP, and the protein FinO upregulates the expression of FinP to reduce F transfer 10 - 2000 fold 
(Koraimann et al., 1996). The representative member of the IncF family, the F plasmid, is classified 
as ‘derepressed’ as it has an insertion sequence 3 (IS3) element in the finO gene, and the finP gene 
has extremely low expression (Frost et al., 1994). This results in high constitutive expression and 
perpetual transfer of the F plasmid. The T4SS of the F plasmid and its conjugative process will be 
detailed in the following sections.     
In bacterial mating, conjugative pili are assembled and extended from T4SS to bind a 
neighbouring cell, then retracted to bring the potential recipient cell in close proximity to the donor 
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cell such that a mating bridge can be formed (Schröder and Lanka, 2005). Pilus assembly requires 
the processing of propilin into pilin, TraA, through the cleavage of a ~50 amino acid (aa) leader 
peptide by Leader peptidase B and the subsequent acetylation of the N-terminus by TraX 
(Arutyunov and Frost, 2013). TraQ acts as a chaperone and allows for the correct insertion and 
accumulation of TraA in the inner membrane to prime the protein subunits for assembly (Lawley 
et al., 2003). TraQ and TraX are subunits specific to the F pilus. A depiction of the F pilus 
displaying the T4SS subunits is shown in Figure 1.2A. 
A multitude of T4SS auxiliary proteins perform the assembly of the pilus tip; the ATPase 
TraC is responsible for extracting the TraA monomers from the inner membrane and provides 
energy for their assembly (Kerr and Christie, 2010). Other proteins known to be responsible for 
pilus tip assembly include TraL, TraE, TraK and the N-terminal half of TraG; where one or more 
of these subunits are predicted to act as a chaperone to attach a molecule of IM phospholipid to 
each assembling TraA subunit (Costa et al., 2016; Hu et al., 2019). Polymerization of the pilus 
occurs in a stoichiometric complex with phospholipid molecules and forms a five-start helical 
assembly, where each strand is composed of 12.8 subunits per helical turn (Costa et al., 2016). 
This creates a protein nanotube with an outer diameter of 87Å and an inner diameter of 28Å. To 
promote assembly of TraA subunits from the base of the pilus and extend the nanotubule, the 
structural stalk and channel proteins TraB, TraK and TraV are required (Lawley et al., 2003). 
 
1.3.3 Pilus Retraction and Exclusion Events 
When the pilus comes in contact and attaches to a neighbouring cell, a signalling event 
occurs and the retraction of this pilus is performed by subunits TraF, TraH, TrbI, and interacting 
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partners TraW and TrbC (Arutyunov and Frost, 2013; Lawley et al., 2003; Shala-Lawrence et al., 
2018) . Many of these proteins have multiple proposed functions; TrbB and TraF both contain 
thioredoxin-like domains and are thought to be responsible for chaperone activity, and aid in the 
correct conformational folding of TraH, TraU, and TraN into the transferosome complex in the 
final mating pair formation step (Arutyunov et al., 2010; Lento et al., 2016).  
 
 
 
 
 
 
 
 
 
 
Figure 1.2. A) The structure of the canonical gram-negative T4SS, the F pilus. Components are 
colour coded based on their function; proteins in fuchsia are responsible for pilus assembly, 
orange-labeled proteins are structural, those in dark blue are for pilin processing, in light blue are 
components responsible for pilus retraction and mating pair formation, mating pair stabilization 
proteins are in green, and exclusion proteins are in red (Arutyunov and Frost, 2013). The N-
terminal transmembrane region of TraG is responsible for pilus assembly, however the protein as 
a whole is considered to be important for mating pair stabilisation; the periplasmic C-terminus is 
predicted to interact with TraN to aid in the stabilization of the conjugative pore (Klimke and Frost, 
1998). Adapted from (Lawley et al., 2003). B) A basic representation of the proposed mechanism 
by which entry exclusion functions in preventing donor-donor transfer of plasmids with identical 
exclusion genes. If neighbouring bacteria hold the same plasmid they will have cognate TraS and 
TraG in their inner membranes (Audette et al., 2007). As conjugation proceeds, if surface 
exclusion malfunctions then entry exclusion is essential in preventing wasteful donor-donor gene 
transfer; the C-terminal region of TraG interacts with its cognate TraS on the neighbouring cell’s 
inner membrane, preventing conjugative transfer and separating the mating junction.    
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After a potential recipient cell is brought in proximity to the donor, mating pair stabilization 
(Mps) occurs. Mps is a multistep process where the OM of neighbouring cells come in close 
contact and exclusion events occur to prevent donor-donor transfer (Arutyunov and Frost, 2013). 
The first step in Mps involves interaction between TraN on the OM of the donor cell with OM 
protein A (OmpA) and LPS moieties on the recipient cell to maintain close contact during 
conjugation (Klimke and Frost, 1998). Next, surface exclusion (Sfx) occurs as mediated by the 
OM lipoprotein TraT; if cognate TraT is expressed in the recipient cell’s membrane indicating the 
presence of the same plasmid in the recipient cell, then an interacting partner (currently not 
established) is theorized to prevent mating pore formation and conjugation will be prevented 
(Garcillán-Barcia and de la Cruz, 2008). If this quality control step fails, then entry exclusion (Eex) 
is relied upon to prevent donor-donor DNA transfer. The IM protein TraS and the periplasmic C-
terminal half of TraG are interacting partners in this event; if the potential recipient has the same 
plasmid TraG in the donor cell is thought to scan the IM of the recipient cell and interact with the 
cognate TraS to arrest conjugation (Figure 1.2B)(Audette et al., 2007). If the recipient cell does 
not have a cognate TraS in its IM, and thus does not have the same plasmid, the C-terminus of 
TraG is predicted to extend to contact TraN in the OM and further the formation of the mating 
junction (Klimke and Frost, 1998). 
  
1.3.4 Conjugative DNA Transfer 
As part of the conjugation process, the DNA to be transferred is processed through the 
formation of a nucleoprotein complex using TraM and the relaxase TraI, which nicks circularized 
plasmid DNA at the origin of transfer (oriT) to form a single stranded DNA (ssDNA) topology. 
TraM binds as a tetramer to aid in DNA unwinding and chaperones the complex to the IM mating 
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pore formed by TraD, a hexameric ring ATPase that pumps the nucleoprotein complex through 
the pore into the recipient cell when all other T4SS have performed their function for mating pair 
formation (Mpf) (Lu et al., 2008; Peng et al., 2014). Rolling circle replication allows for 
asymmetric replication of the ssDNA in the donor cell, thus reforming the plasmid while the 
mobile ssDNA is being transferred to the recipient cell (Wawrzyniak et al., 2017). In the recipient 
cytoplasm the nucleoprotein complex is removed and the ssDNA is recircularized and replicated, 
thus converting the recipient cell into a donor for the newly integrated genes (Arutyunov and Frost, 
2013; Guglielmini et al., 2014). 
   
1.4 The F plasmid and F pilus 
The Fertility (F) plasmid was the first factor confirmed by Joshua Lederberg and Edward 
Tatum to be responsible for bacterial conjugation in the model organism Escherichia coli K-12, 
indicating the prevalence of the F plasmid in molecular biology (Tatum and Lederberg, 1947). As 
in all conjugative plasmids, the F plasmid contains all genes an F+ cell requires to properly perform 
a donor-recipient conjugative DNA transfer. In related plasmids these genes are titled vir for 
virulence, however in the F plasmid they are the tra (for transfer) genes (Fernandez-Lopez et al., 
2016). The nomenclature difference results from the distinction of F plasmid from other sex-
related plasmids, such as those that code for P, N, W, or X pili. The genetic region involved in F 
conjugation is significantly longer (~34kb) and contains more genes than those of VirB/D4-like 
pili forming plasmids (~15 kb) (Lawley et al., 2003). Additionally, all tra genes are transcribed 
from a single promoter, making the 34kb tra operon the longest transcript found in E. coli. This 
transcript consists of genes coding for the core complex proteins required for conjugation; 
including DNA transfer proteins such as the relaxase and chaperone proteins that form the 
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nucleoprotein complex with the ssDNA to cross the mating bridge, as well as the components of 
the conjugative pilus and the pumping platform for the nucleoprotein complex (Arutyunov and 
Frost, 2013). Other proteins include those responsible for Mps, Sfx to prevent contact of two F+ 
cells, and Eex to prevent donor-donor transfer. An image of the genetic order of the F plasmid is 
shown in Figure 1.3 with a more detailed view of the tra region.  
Figure 1.3: The anatomy of the F plasmid, approximating positions of important genetic markers 
in a 100kb map. The origin of transfer (oriT) represents the position where TraI nicks the plasmid, 
the small black triangle represents the direction of ssDNA transfer. Insertion sites 2 and 3 (IS2 & 
3) and Tn1000 represented by black boxes are simple and composite transposable elements, 
respectively (Roberts et al., 2008). RepFIA and B are replicons which function as origins of 
replication, while the FIC replicon is non-functional (Villa et al., 2010). The leading region 
contains many genes involved in the regulation of the tra genes and their gene products; for more 
information see (Manwaring et al., 1999). The transfer region is the 34kb tra operon; all tra and 
trb genes are shown, as well as antisense genes artA and finP (Frost et al., 1994). I* represents a 
gene product predicted to be expressed within the traI gene, but later this gene region was 
determined to be a separate domain of the TraI protein responsible for DNA transfer activity 
(Matson and Ragonese, 2005). The colours are coded in the same fashion as in Figure 1.2A; 
however yellow genes are those involved in conjugation signalling, origin nicking, relaxase 
activity, and T-DNA transport. White genes are those with no known function to date. Figure 
adapted from (Firth et al., 1996; Laura S Frost et al., 1994). 
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The pili assembled by T4SSs can be categorized by their size and rigidity, which typically 
dictates their function (Arutyunov and Frost, 2013; Bradley, 1980). Thin flexible pili confer Mps, 
while rigid pili are encoded by T4SS that have an additional ATPase, VirB11 (orthologous to 
TrbB), and perform Mpf but do not perform Mps or pilus retraction (Arutyunov and Frost, 2013). 
Thick flexible pili are characteristic of the more complex T4SS that are involved in pilus retraction, 
Mps, and Mpf. The F pilus is the representative member of the thick, flexible T4SS pili, and the 
plasmid encoding it is the best characterized conjugative plasmid in gram-negative bacteria 
(Arutyunov and Frost, 2013; Bradley, 1980). Therefore, the F pilus is an ideal T4SS to study for 
obtaining a representative view of conjugation in gram-negative bacteria and to understand their 
mechanisms of pathogenesis. 
    
1.5 Entry Exclusion and Incompatibility Groupings 
1.5.1 The Discovery of Superinfection Immunity 
Eex is an important function in conjugative systems to prevent the inefficient transfer of a 
plasmid from a donor cell to another cell that has the same plasmid (Frost et al., 1994). After Sfx 
is permitted and cells come in close proximity, Eex is performed before Mpf and completion of 
the mating bridge. TraG in the donor cell is thought to scan the IM of the recipient cell and interact 
with the cognate TraS to arrest donor-donor conjugation (Audette et al., 2007).  This is performed 
in a plasmid specific manner; the TraG proteins of the closely related F and R100 transfer 
apparatuses present in donor cells will recognize their cognate TraS in a recipient cell but will not 
recognize TraS from a homologous plasmid. The result of this phenomenon was seen early in the 
history of conjugation research; Lederberg et al. discovered that cells harbouring the F plasmid 
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were poor F conjugation recipients, and later the inefficient transfer was termed ‘superinfection 
immunity’ (Lederberg et al., 1952; Watanabe, 1963). Superinfection refers to the process of lethal 
zygosis, a phenomenon that was seen when an excess of High frequency of recombination (Hfr) F 
donors were placed in contact with F¯ recipients; many of the recipient cells died (Skurray and 
Reeves, 1973). The primary cause of cell death was determined to be extensive damage in the 
recipient cell membrane resulting in cell permeability due to extensive cell-cell contacts mediated 
by pili during conjugation (Ou, 1980; Viljanen, 1987). Metabolic costs due to excessive DNA 
transfer contribute to lethal zygosis in a lesser extent. F-mediated superinfection immunity is 
attributed to exclusion genes traS and traT, and the exclusion process is essential in preventing 
lethal zygosis through excessive mating (Ou, 1980; Skurray and Reeves, 1974).       
There exists an association between exclusion and sex pilus type; sex factors carrying the 
same sex pilus type would be excluded, however plasmids with different sex factors permit 
conjugation even if the pilus type is identical (Edwards and Meynell, 1968;Meynell and Ewins, 
1973). When the plasmid was transferred to a donor by transduction this phenomena did not occur 
in cells despite an active entry exclusion system, however even when entry exclusion was 
abolished it was observed that any second F factor in an F-containing strain would be removed 
(Dubnau and Maas, 1968; Watanabe et al., 1968). Therefore it was concluded that two 
phenomenon contribute to superinfection immunity: plasmid incompatibility and entry exclusion 
(Garcillán-Barcia and de la Cruz, 2008; Novick, 1969; Watanabe et al., 1968) . 
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1.5.2 Plasmid Incompatibility 
 Incompatibility in mobilizable elements can be defined as the inability of two plasmids to 
be propagated stably in the same cell line (Couturier et al., 1988). It is a manifestation of 
relatedness; elements involved in plasmid replication control and partitioning are identical, causing 
malfunction in the inheritance of both plasmids into the daughter cells. Incompatibility is also 
linked to copy number, as the number of origins of replication of the same grouping affects whether 
they are replicated (Novick, 1987). Speed of replication and toxicity of the plasmid also affects 
the survivability of these plasmids, as outgrowth during replication is theorized as the mechanism 
for the loss of one plasmid in a similar pair (Velappan et al., 2007). As incompatibility is a 
universal property of plasmids, it allows for the formation of a suitable classification scheme 
(Carattoli et al., 2005; Novick, 1987). The main families are considered to be IncF, IncP, IncA/C, 
IncH, IncI, and IncN based on the plasmid multilocus sequence typing database (Jolley and 
Maiden, 2010).  An indeterminate multitude of subfamilies exist due to the continuous discovery 
and synthesis of novel plasmids. 
   
1.5.3 Entry Exclusion in Different Incompatibility Groups 
 Plasmid inclusion families are seen to have differences in their exclusion systems in terms 
of gene organization and the structure of the encoded proteins (Garcillán-Barcia and de la Cruz, 
2008). The previously described exclusion system is that of the IncF-like group, and the genetic 
organisation for Eex and Sfx genes on these plasmids follow the order seen in Figure 1.4. In 
comparing the genetic organisation of plasmid groups from gram-negative bacteria, synteny (the 
physical localisation of genetic loci) is maintained for Eex genes in relation to other transfer-related 
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genes (Garcillán-Barcia and de la Cruz, 2008). Plasmid families have some differences in their 
genetic organisation; many have their traS-like gene before their traG-like gene in the locus, and 
most plasmids do not have a traT-like Sfx gene at all. Many groupings lack a traG-like gene for 
exclusion as well; IncI-like and ICEs R391 and SXT only have a traS-like exclusion gene, and the 
pheromone responding conjugative elements have their own type of exclusion system. Plasmids 
most commonly found in gram-negative bacteria are from the inclusion families shown to have 
both TraG- and TraS- like systems; IncF-like, IncP-like, and IncN-like (includes 
IncW)(Fernandez-Lopez et al., 2016). There exists the potential for evolutionary selection for 
TraG/TraS-like Eex systems against TraT-like Sfx systems, as supported by the observed increase 
in exclusion index (EI) in Eex in comparison to Sfx (Garcillán-Barcia and de la Cruz, 2008).  EI 
is calculated as the frequency of transfer of a plasmid given to a plasmid-free recipient divided by 
the frequency of transfer to a recipient carrying the same plasmid; for the F-plasmid in E. coli the 
EI was 100-300 because mating was observed at 100-300 times higher frequency when the plasmid 
was not present in the recipient in comparison to donor-donor exchange (Achtman et al., 1977). In 
comparing EI of donor-recipient exchanges for the F plasmid, traT point mutants showed a smaller 
reduction in mating than the traS point mutants (Achtman et al., 1980). An increased exclusion 
activity was seen in the Eex system, which was attributed an EI of 200, while an EI of 20 was 
associated to the Sfx system. indicating a higher reliance on the Eex system for preventing 
erroneous donor-donor transfers. The exclusion process performed by these systems is also seen 
to be gene-dose dependent; when traS and traT were cloned into a multicopy plasmid the EI 
increased to 10,000 (Achtman et al., 1977).    
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Figure 1.4: Genetic organization of the exclusion gene-containing regions in the plasmid 
incompatibility groups: A) IncF-like; B) IncP-like; C) IncN-like; D) IncI-like; E) IncH-like; F) 
ICEs R391 and SXT; G) ColE1-like; H) Pheromone-responding conjugative plasmids, more 
commonly found in gram positive bacteria. Arrows corresponding to the direction of transcription 
in exclusion genes are shadowed depending on the system; light gray is for exclusion genes of 
pheromone-responding conjugative plasmids, intermediate gray for genes encoding inner 
membrane exclusion proteins similar to traS and dark gray representing genes encoding outer 
membrane exclusion proteins similar to traT. traG homologs are dashed, while bordering genes 
with different functions are filled in white. Figure from (Garcillán-Barcia and de la Cruz, 2008). 
 
In comparing traS genes for different incompatibility groupings, low sequence homology 
is observed even in members of the same inclusion family. TraT from the plasmid pED208 
(TraTpED208) of the IncF family has the lowest inter-family protein homology to TraTF at 80% aa 
identity, however TraSpED208 has no identity to TraSF or TraSR100 (Garcillán-Barcia and de la Cruz, 
2008). Even the closely related F and R100 plasmids show a TraS homology of only 17% with no 
region displaying greater identity (Figure 1.5A)(Audette et al., 2007).  
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Exclusion genes have proven to be important for the stability of a conjugative plasmid; F 
mutants with both traS and traT mutations are unstable and have not been isolated (Achtman et 
al., 1980, 1977). This is supported by F plasmid-mediated superinfection immunity, which was 
determined to be mediated by TraT and TraS (Ou, 1980). The presence of TraS however was 
deemed to be more important for colony survival than TraT (Garcillán-Barcia and de la Cruz, 
2008; Ou, 1980). As Eex by TraS and TraG also provide a higher EI than Sfx by TraT, it is 
theorized that the disruption of Eex systems would be severely detrimental to bacterial colony 
survival (Garcillán-Barcia and de la Cruz, 2008).   
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Figure 1.5: Sequence alignment of entry exclusion proteins A) TraS and B) TraG in related F-like 
plasmids F and R100 as aligned by Clustal W (Thompson et al., 1994). Strictly, highly and 
moderately conserved residues are indicated by the symbols ‘*’, ‘:’ and ‘.’, respectively. TraS 
proteins have an overall sequence identity of 17 %, and the predicted transmembrane helices are 
boxed (Audette et al., 2007). For TraG, the region between residues 610 and 673 (boxed) displays 
the greatest dissimilarity between the two proteins, at 55.7% identity versus 93% overall identity 
between the two proteins. Five transmembrane helices (aa 54–73, 327–348, 364–385, 407–426 
and 428–447) in the N-terminus are indicated by cylinders above the sequences. The predicted 
signal peptidase cleavage site is at residue 451, and the residues forming the ‒3 to +1 peptidase 
region (aa 449–452) are underlined. Images adapted from (Audette et al., 2007). 
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1.6 Characteristics of TraG and TraG*from the F plasmid  
1.6.1 Insights on TraG Structure and Function  
 F TraG (TraGF) is a 102.5 kDa protein with an N-terminal transmembrane domain bound 
in the IM and a periplasmic C-terminal domain from residues A452-E939 denoted TraG* (Audette 
et al., 2007). It is one of the largest proteins encoded by the tra region of the F plasmid. Frameshift 
mutations in the C-terminal domain affect Mps while frameshift mutations in the N-terminus affect 
the polymerisation of pilus subunits (Willetts and Achtman, 1972). It was thought that the presence 
of a signal peptidase I cleavage site after residue A451 releases TraG* into the periplasm to fulfill 
its role in Mps (Firth and Skurray, 1992). However TraGF must have both domains intact in order 
for Mps to occur (Audette et al., 2007). This indicates that TraG* does not become cleaved to 
function as a separate protein, and therefore there is a strong dependence on intact TraG for 
performing Mps and Eex. In performing Eex, TraG is predicted to scan the neighbouring recipient 
IM to interact with TraS, which would require the protein to interact over two layers of OM. This 
distance can be approximated to 35-40 nanometers (nm), assuming donor and recipient cell 
membranes are proximal after Sfx (Silhavy et al., 2010). As this distance is likely unachievable by 
a single globular protein, the C-terminal region of TraG is theorized to undergo a reversible 
conformational change and thrust into the mating pore formed after TraN interacts with OmpA of 
the recipient cell (Audette et al., 2007). In this predicted model TraG maintains an intact structure 
and extends TraG* through the mating pore into the periplasmic space of the recipient cell to 
perform its role in entry exclusion. A TraS-TraG complex has not been detected in mating cells 
through crosslinking or immunoprecipitation experiments, nor interaction detected using a 
bacterial two-hybrid system (Audette et al., 2007). As well, interaction between TraN and TraG 
has not been detected using similar methods (Klimke et al., 2005). The likely cause for the lack of 
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detectable assembly is due to the small number of interacting protein partners in a mating pair, as 
well as the transient nature of the protein-protein interactions (PPIs). 
Audette and colleagues determined that there is a region in the aa sequence of TraGF and 
TraGR100 that shows 55.7% similarity while the proteins hold an overall sequence identity of 93% 
(Figure 1.5B)(Audette et al., 2007).  Residues T610-A673 were predicted to be responsible for the 
trans-exclusive interaction between TraG and a cognate TraS, as TraG will not interact with TraS 
in the same IM. The F and R100 TraS sequences have an overall sequence identity of 17% despite 
the overall homology of these plasmids. Lack of protein homology in the TraS family for the full-
length protein, and in the TraG family for residues T610-A673, indicates that these proteins are 
responsible for plasmid specificity in the Eex process. As residues T610-A673 are within the 
domain of TraG termed TraG*, studying the structure of the periplasmic domain has the potential 
to elucidate the mechanism by which TraG interacts with the cognate TraS of a recipient cell to 
perform Eex.  
 
1.6.2 Solved Structures of Proteins Analogous to TraG  
Currently there is a lack of structural data for TraG*. In the IncN-type plasmids the model 
T4SS is the Ti pilus from Agrobacterium tumefaciens, largely due to the utility of this system in 
the genetic modification of plants mediated by the Ti plasmid (Christie, 2004; Valvekens et al., 
1988). Figure 1.4C shows the plasmid pCRY (similar to the Ti plasmid) contains the gene product 
VirB6, a protein orthologous to TraG*. While there are no structures of VirB6 solved, the structure 
of VirB8 orthologous to the N-terminus of TraG has been solved in numerous species; A. 
tumefaciens, Brucella suis, Bartonella quintana, Bartonella tribocorum, and Rickettsia typhi 
 20 
 
(Bailey et al., 2006; Gillespie et al., 2015; Smith et al., 2012). As well, TraH, a VirB8 homolog 
from the plasmid pIP501 (from IncN family, similar to pIPO2T) in Enterococcus faecalis was 
solved (Fercher et al., 2016). All of these structures feature a Nuclear Transport Factor 2-like fold 
and show high structural homology despite low sequence homology, with backbone root mean 
square deviation (rmsd) values ranging between 2.6–2.8 Å in comparing all structures (Fercher et 
al., 2016). These VirB8 structures indicate the protein functions as a dimer, however TraH is 
monomeric. However, a VirB8 homolog from pKM101, TraE, was shown to form hexamers when 
isolated and when interacting with the VirB6 homolog from this plasmid, TraD, thus implying the 
diversity in oligomerization possible in these systems (Casu et al., 2018). These studies indicate 
the potential for TraG to have an N-terminus similar in structure to VirB8 despite low sequence 
homology, and therefore may function as a monomer, a dimer or a hexamer. As TraG* is separated 
from this N-terminus there is the potential that the protein will not oligomerize without the 
membrane-bound half. There is evidence indicating the evolution of the traG gene in the F plasmid 
involved the fusing of an ancestral homolog of genes virB6 and virB8 to produce a single gene 
(Christie, 2016).  
 
1.7 Intrinsic Disorder in Proteins  
1.7.1 Common Functions of Dynamic Proteins 
 The importance of intrinsically disordered regions (IDRs) in proteins was understated for 
much of the history of structural biology (Uversky, 2013). The prominent view of protein function 
was that the amino acid sequence dictates a highly specific three dimensional structure inherent in 
its activity (Dunker et al., 2002). However disorder in a protein sequence plays an important role 
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in its function; disordered regions of proteins are commonly involved in PPIs, protein-nucleic acid 
binding, phosphorylation, or as flexible linkers (Dunker et al., 2002; Dyson and Wright, 2005; 
Reddy Chichili et al., 2013). A continuum to the extent of disorder intrinsic to a native protein 
structure is observed, from well-defined single domain folds, to multidomain proteins with 
disordered flexible regions, to disordered molten globules, and to extended random coils (Dyson 
and Wright, 2005; Mittag et al., 2010). Figure 1.6 displays examples of proteins in which the 
degree of intrinsic structural disorder is relevant to its function.  
 The occurrence of unstructured regions >50 residues is common in functional proteins 
(Dyson and Wright, 2005; Uversky, 2013, 2002). Intrinsically disordered proteins (IDPs) are more 
common in eukaryotes and viruses due to the requirement of complexity in their morphologies; it 
is suggested that there exists a link between intrinsic disorder and evolution (Xue et al., 2012). 
There are many examples of prokaryotic IDPs however, such as the proteins that regulate the 
assembly of large multiprotein complexes such as FlgE in the bacterial flagellum (Barker et al., 
2017), and Ffh and FtsY of the ribosome (Dyson and Wright, 2005; Estrozi et al., 2011; Focia et 
al., 2004). In both cases there exists an intrinsically disordered region (IDR) that serves as a linker 
region for two independent functional domains required in achieving a variety of conformations 
for important PPIs. As well, several bacterial regulatory proteins have conserved short intrinsically 
disordered linker regions called Q-linkers (Dyson and Wright, 2005; Reddy Chichili et al., 2013; 
Wootton and Drummond, 1989). Therefore, it is not uncommon in bacterial proteins for disordered 
regions to be important flexible linkers of folded domains.  
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Figure 1.6: The top panels show the paradigmatic continuum of protein structure, with the degree 
of conformational order increasing from left to right, and examples therein. The activator for 
thyroid hormone and retinoid receptors (ACTR) is an example of an unstructured conformational 
ensemble and exists as random coils in solution (Martinez-Yamout et al., 2002). An example of 
the next milestone in protein dynamics is the molten globule nuclear receptor co-activator binding 
domain (NCBD) of the cyclic-AMP-responsive-element-binding protein (CREB)-binding protein 
(CBP). As seen in the bottom left panel, ACTR functions as a cryptic binding protein to form a 
mutually folded structural complex with the NCBD of CBP. The zinc finger of transcription factor 
IIA displays conformational freedom in linkages between folded domains, and finally the free 
eukaryotic translation initiation factor (eIF)4E displays high order with limited local disorder 
(Dyson and Wright, 2005; Gross et al., 2003). The remaining bottom two panels show the way 
these proteins interact with targets based on the stability of their three-dimensional structure. 
Figure from (Dyson and Wright, 2005). 
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1.7.2 Pi-Pi Interactions in Disordered Regions of Proteins 
 Protein phase separation is driven by numerous physical principles and chemical 
interactions; multivalent, electrostatic, cation-pi, pi-pi, and the hydrophobic effect have all been 
proposed to contribute to this phenomenon (Kim et al., 2016; Li et al., 2012; Lin et al., 2016; 
Vernon et al., 2018; Yeo et al., 2011). Phase separation occurs when a supersaturated solution of 
a molecule spontaneously separates into two phases, a dense phase and a dilute phase, that then 
stably coexist (Boeynaems et al., 2018; Li et al., 2012). It is a demixing of a homogeneous solution 
such that distinct regions are occupied by distinct species, as promoted by the reversable self-
concentration of a protein yielding phase separations; from liquid-liquid, to liquid-gel, to liquid-
solid. Phase separations by proteins are important as they are implicated in the formation of 
membraneless organelles for cellular organization, signaling, RNA processing, biopolymerisation 
and pathological aggregation (Mitrea and Kriwacki, 2016; Sfakianos et al., 2016; Su et al., 2016; 
Taylor et al., 2016). Many phase separating proteins have large IDRs that do not form a stable 
folded structure (Boeynaems et al., 2018). Interactions with solvent are typically in competition 
with non-covalent bonds at the surface of a well-folded protein, such as protein-protein hydrogen 
bonds (Efimov and Brazhnikov, 2003). However interactions common in IDRs, such as planar pi-
pi interactions, are predominant in these regions, and as there is a lack of competition with water 
molecules for pi-pi contacts solvation of hydrogen bond donors and acceptors is promoted in these 
regions (Efimov and Brazhnikov, 2003; Vernon et al., 2018). High levels of solvent interaction 
can be detected through Hydrogen Deuterium Exchange Mass Spectrometry (HDX MS) as the 
availability of backbone and sidechain hydrogen atoms in IDRs promotes a rapid exchange profile 
(Kaltashov et al., 2013; Oganesyan et al., 2018; Resetca and Wilson, 2013).  
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Pi-pi interactions are non-covalent bonds and involve p orbitals of atoms consisting of one 
electron interacting with another single occupancy p orbital, where one orbital is electron rich and 
the other is electron poor as caused by the atom’s proximal covalent bonds (Haugh and 
Hirschfelder, 1955; Kertesz, 2019). These interactions are commonly associated with aromatic 
rings where induced quadripolar interactions provide the non-covalent bonds formed by π (pi) 
orbitals; these orbitals are present in any bound sp2 hybridized system. As the 20 amino acids all 
have peptide bonds, which feature sp2 hybridized orbitals throughout the atoms of the planar amide, 
there is a potential for every residue in a protein to perform this interaction (McGaughey et al., 
1998; Vernon et al., 2018). However, those amino acids with small side chains that leave the 
peptide backbone exposed; Gly, Ser, Thr and Pro, are residues in which amide pi orbitals 
commonly perform this interaction in proteins. As mentioned, aromatic rings stack to perform pi-
pi interactions and therefore amino acids Tyr, Phe and Trp also participate using their side chains 
(McGaughey et al., 1998; Riley and Tran, 2017; Vernon et al., 2018). Other side chains with 
conjugated pi systems in their side chains include His, Gln, Asn, Glu, Asp and Arg (McGaughey 
et al., 1998; Vernon et al., 2018).  
While any combination of pi-pi interaction is possible between residues in an IDR, it was 
found that the vast majority of contacts involve one of the six amino acids containing side chains 
with non-aromatic sp2 hybridized atoms, or the peptide bond (Vernon et al., 2018). 36% of all 
observed pi-pi interactions occurring throughout solved protein structures in the PDB do not 
involve an aromatic residue, and that face-to-face contacts of peptide bonds occur as often as 
aromatic face-to-face contact. As mentioned earlier, solvation is high in IDRs and it was 
recognized that there is a high correlation between the number of water contacts and the probability 
that a residue is involved in a pi-pi contact. It was also found that planar pi-pi interactions occur 
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more often at positions associated with disorder, as they have an overall secondary structure with 
less rigidity. This is especially true of regions responsible for phase separation. Of the phase 
separating IDRs solved in the PDB the single property of long-range (≥5 residues apart or different 
chains) pi contact propensity is sufficient for marking them as outliers in comparison to the rest of 
the proteome. Through these principle properties, Vernon and others were able to make a novel 
software predicting IDRs in a protein based on propensity for pi-pi contacts (Vernon et al., 2018). 
Their work showed that most phase separating proteins can make significant non-local planar pi-
interactions and based on their primary sequence analysis method, IDRs recognized with this 
engine have a high propensity for phase separation. 
   
1.8 Topic of Research: Structural Study of TraG*  
Determining the high-resolution structure of proteins involved in entry exclusion would be 
beneficial in further understanding the mechanisms of the conjugation process. However, IDRs in 
a protein would interfere with the generation of an ordered protein crystal, a necessity in the 
generation of a high-resolution diffraction pattern. The main hypothesis of the research described 
herein was that TraG* contained an N-terminal IDR; removal of this predicted IDR should result 
in increased protein stability and crystallization ability. TraG*F, rather than intact TraGF, was 
chosen for study due to the hydrophobic, membrane-bound N-terminal region of the full-length 
protein. Intermembrane proteins tend to aggregate at concentrations required for crystallisation, 
requiring specialized crystallization methods, thus providing difficulty in the purification and 
structural solution of proteins involved in entry exclusion such as TraG and TraS (Bayburt and 
Sligar, 2010). As well the large size of TraGF would make the full-length protein challenging to 
overexpress in E. coli. Therefore TraG* was chosen to be expressed due to its reduced size and 
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ease of purification, as its solubility in the periplasm will permit cytoplasmic expression. 
Furthering the importance of this study is the encompassing of the predicted region involved in 
performing TraS interactions within the TraG* sequence (Audette et al., 2007). As the F pilus is 
the representative member of gram-negative conjugative T4SS, an understanding of the entry 
exclusion process of this system has the potential to develop a new paradigm for the conjugative 
process. Disrupting Eex to promote ceaseless conjugation thus causing lethal zygosis, or to prohibit 
conjugation completely, could allow for the development of a novel class of antibiotics that 
reduces the proliferation of antibiotic resistance.   
This thesis will discuss the issues arising in TraG*F protein crystallisation that led to the 
hypothesis that the N-terminal residues of TraG* are intrinsically disordered. This hypothesis was 
supported by novel structural prediction software based on long range planar pi-pi interactions 
(Vernon et al., 2018). This allowed for the design of a truncation mutant of the N-terminal 45 
residues of the protein; termed TraG*∆, the protein begins at Thr497 of the TraGF (Figure 1.7)(See 
Appendix A for Sequence Information). Constructs of C- and N- terminally hexahistidine (His6) 
tagged TraG* and TraG*∆ were cloned, expressed and purified (Table 1.1). Performing subsequent 
global HDX MS, circular dichroism (CD) and thermofluor assays confirmed that removal of this 
region enhances protein stability, and comparisons to the full-length TraG* confirm the truncated 
region behaves in a manner characteristic of high dynamicity. It is theorized that this region serves 
as a flexible linker between the membrane-bound N-terminal domain of TraG responsible for pilus 
assembly and the periplasmic C-terminal domain responsible for interacting with both TraN and 
TraS, thus providing the inherent flexibility required for mediating TraG* contacts.   
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Figure 1.7: Schematic of TraGF, TraG* and TraG*∆. The N-terminal domain in fuchsia from V1-
A451 is inner membrane bound and responsible for pilus assembly, and the C-terminal domain in 
green from A452-E939 termed TraG* is responsible for Mps an Eex. The region from A452-A496 
is hypothesized to be highly dynamic, and the protein from T497-E939 is termed TraG*∆. This 
construct contains the non-homologous region from R610-D673 predicted to be responsible for 
interacting with TraS to perform Eex.   
 
 
Table 1.1: A comprehensive list of the TraG* protein variants used in this study, as well as the 
plasmid they were expressed from and their respective abbreviations. Full protein sequence 
information is listed in Appendix A.  
Protein  Plasmid Abbreviations TraG Residues 
C-terminally His6-tagged TraG* pET28a:G*His TraG*His, G*His 
A452-E939 
N-terminally His6-tagged TraG* pET28a:HisG* HisTraG*, HisG* 
C-terminally His6-tagged TraG*∆ pET28a:G*∆His TraG*∆His, G*∆His 
T497-E939 
N-terminally His6-tagged TraG*∆ pET28a:HisG*∆ HisTraG*∆, HisG*∆ 
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CHAPTER 2.0 ‒ MATERIALS AND METHODS  
2.1 Reagents and Equipment  
 All chemicals and antibiotics used in this study were purchased from Sigma-Aldrich, 
VWR, Thermo-Fisher, and BioBasic unless otherwise indicated. Restriction Enzymes and cloning 
reagents were purchased from New England Biolabs (NEB); DNA ladders and protein markers 
were purchased from Thermo-Fisher. Qiagen and Anatrace crystallisation screens were used for 
initial vapour diffusion experiments. Plasmid vectors pET28a, pET28a:G* and pET28a:G*His as 
well as E.coli BL21 (DE3) and DH5α were obtained from cryogenic lab stocks. Primers purchased 
from Integrated DNA Technologies (IDT) used in this study are listed in Table 2-1.  
 Polymerase Chain Reaction (PCR) was performed using a TECHNE TC3000-G 
thermocycler. All sonication was carried out using a Sonic Dismembrator 5000 (Ficher Scientific). 
Liquid chromatography was performed utilizing an ÄKTA purifier 10 from General Electric (GE) 
Healthcare using columns from GE and Wyatt. Agarose and Sepharose resins for protein 
purification were from Fisher Scientific. Concentration and dialysis of proteins was performed on 
30,000 Dalton (Da) Molecular weight cut-off (MWCO) centrifugal concentrator (Millipore, 
Corning). DNA quantification was estimated using a NanoDrop 2000 spectrophotometer (Thermo 
Scientific). Protein quantification assays were conducted using a Synergy H4 Hybrid microplate 
reader from BioTek. Electrospray ionization mass spectrometry was performed on a Waters Synapt 
G1 operating in positive ion mode. Circular Dichroism experiments were conducted on a J-815 
CD Spectrometer from Jasco. Dynamic Scanning Fluorimetry (Thermofluor) experiments were 
performed on a RotorGene Q qPCR from Qiagen and SYPRO orange was used to detect protein 
unfolding (Life, ThermoFisher). Observations of crystallisation experiments were carried out 
using a Nikon SMZ1500-Fibre Lite MI 150 stereoscopic microscope. 
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Table 2.1: Primers used in the creation of plasmid constructs pET28a:HisG*, pET28a:HisG*∆ and 
pET28a:G*∆His. The underlined portion of the primer sequences show their respective restriction 
enzyme cut sites. 
Construct Restriction 
Enzyme 
Tm 
(°C) 
Primer Sequence (5ˈ‒3ˈ) 
pET28a:HisG*_Fwd BamHI 55 TTAGGATCCGCAGGCAGTGTGTTG 
pET28a:HisG*_Rev HindIII 56 CGCGAAGCTTTTATTCTTTATGCTGGTAACTCTTTGC 
pET28a:HisG*∆_Rev 
pET28a:HisG*∆_Fwd BamHI 62 CGAGGATCCACACAGACCCGTGACGGTAATATG 
pET28a:G*∆His_Fwd NcoI 61 CGACCATGGACACAGACCCGTGACGGTAATATG 
pET28a:G*∆His_Rev HindIII 56 CGACAAGCTTTTCTTTATGCTGGTAACTCTTTGC 
 
2.2 Analysis of TraGF Using Software for the Detection of Disorder  
 The primary sequence of TraGF was input into the analysis servers PrDOS, DisEMBL 1.5, 
SCRATCH, MFDp2, IUPred2A, Phyre2, I-TASSER, and the IDR Phase Separator Predictor (PSP) 
(Cheng et al., 2005; Dosztányi et al., 2009; Linding et al., 2003; Magnan and Baldi, 2014; 
Mészáros et al., 2018; Mizianty et al., 2013; Roy et al., 2010; Vernon et al., 2018). Decisions in 
designing primers for cloning of a TraG* mutant were based on the results of these analyses.  
 
2.3 Cloning of TraG* Constructs 
2.3.1 Plasmid Extraction of pET28a   
 Overnight cultures of DH5α E. coli with plasmids pET28a and pET28a:G*His were 
prepared in 10mL Luria Bertani broth (LB) with 50μg/mL Kanamycin (Kan) at 37°C with shaking 
at 200 rotations per minute (rpm). Plasmid extraction was performed using the GeneJET plasmid 
miniprep kit from Thermo-Fisher following the manufacturer’s protocol. The extracted plasmids 
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were quantified using a NanoDrop 2000 Spectrometer from Thermo Scientific and qualified using 
a 1.2% agarose gel.  
 
2.3.2 PCR Amplification of traG* and traG*∆  
 Primers were designed based on guidelines from IDT and analyzed using the IDT 
OligoAnalyzer®. Melting temperatures were maintained within 5°C between forward and reverse 
primers, GC content was between 35-65%, and the free energy to generate self-dimers, hairpins or 
heterodimers was kept above -9.0kcal/mol.  Q5 DNA polymerase was used to amplify the genes 
from 200ng of pET28a:G* plasmid. The PCR protocol was performed as follows: initial 
denaturation at 98°C for 30s, then 30 cycles of denaturation, annealing and extension at 98°C for 
10s, 55°C for 20s, and 72°C for 28s respectively. Then a final extension was performed at 72°C 
for 10 minutes. PCR products were purified using the GeneJET PCR Purification kit from Thermo-
Fisher following the manufacturer’s protocol. Amplicons were then quantified by NanoDrop 2000 
and qualified using a 1.2% agarose gel. 
   
2.3.3 RE Digestion, Ligation and Transformation of traG* Mutants into pET28a 
 The pET28a vector and purified amplicons were double digested using the appropriate 
restriction enzymes (RE) in 1X NEB CutSmart Buffer. 1μg of DNA was digested with 20,000 
units of each RE at 37°C for 30 minutes. After this incubation, 1 unit of Calf Intestinal Alkaline 
Phosphatase (CIP) was added to the double digested (DD) pET28a samples to de-phosphorylate 
the 5ˈ and 3ˈ ends of the linearized plasmid to prevent self-ligation. These samples were then 
incubated for an additional 30 minutes at 37°C. DD plasmids and amplicons were then isolated 
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through separation on a 1.2% agarose gel by performing electrophoresis at 100V for 40 min, 
followed by gel extraction using the GeneJET Gel Extraction kit from Thermo-Fisher using the 
manufacturer’s protocol. The DNA samples were then quantified by NanoDrop 2000.   
NEBs ligation calculator was then used to design ligation experiments in 1:5 and 1:7 
proportions of plasmid to amplicon, and a plasmid self-ligation control. Ligation was performed 
overnight at 4°C using T4 DNA ligase in proportions described by the manufacturer’s protocol. 
Heat inactivation was performed at 65°C for 10 minutes, and after cooling at 4°C 5μL of the 
ligation reaction was added to 90μL of DH5α competent cells (protocol for the generation of 
competent cells found in Appendix B). The cells were incubated at 4°C for 20 min, heat-shock 
transformed at 42°C for 90 seconds, cooled at 4°C for 5 minutes and then incubated at 37°C for 1 
hr following the addition of 900μL of LB to equilibrate the transformed cells. The cells were spun 
down at 5000 x g for 10 minutes at room temperature, then resuspended with 100μL of LB. 30μL 
of each cell resuspension was spread plated onto a LB Kan+ (50μg/mL) plate, as well as control 
plates LB Ampicillin+ (100μg/mL) and LB with no antibiotic to check for cell viability. Plates 
were kept at 37°C for 16-24 hrs.  
Colonies grown from LB Kan+ plates were aseptically picked and used to inoculate 10mL 
of LB Kan+ which was then incubated at 37°C overnight. Plasmid extraction was performed as 
described in Section 2.2.1 and restriction enzyme digestion was performed as described above to 
check for insertion of the proper gene through performing agarose gel electrophoresis. The 
plasmids with the correct insert size were sent to BioBasic (Markham, ON) for dideoxy sequencing 
of the multiple cloning site using the T7 Promoter and Terminator universal sequencing primers. 
Plasmids determined to have the correct traG* genes inserted in the proper frame were used to 
transform BL21 (DE3) competent cells as in the above heat shock protocol.  
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2.4 Expression and Purification of TraG* Mutants 
2.4.1 Optimization of TraG* Expression  
 Initial expression trials of untagged TraG* and TraG*His were performed previously at 
37°C (Ergodan, 2016). A purification after 16°C overnight incubation was performed on TraG*His 
and results were compared to purifications performed at 37°C for 4 hours. The optimized protocol 
follows: a 10mL feeder culture of BL21 E. coli with the desired TraG* plasmid construct was 
grown in LB with 50µg/mL Kan overnight at 37°C. This feeder culture was used to inoculate 1L 
of LB with 50µg/mL Kan and 1mM Glucose. After the 1L culture had reached the mid-logarithmic 
growth phase (OD600nm = 0.5 ‒ 0.8), ethanol was added to a final concentration of 1% to induce a 
stress response and promote chaperone protein assembly (Chhetri et al., 2015). Expression of the 
TraG* variant was then induced through addition of IPTG to a final concentration of 1mM. An 
incubation was performed for 16 hours at 18°C with shaking at 200rpm, and cells were then 
pelleted at 5,000 x g for 20 min at 4°C. HisTraG*, TraG*∆ His and HisTraG*∆ expressions were 
performed in the same way. 
    
2.4.2 Purification Schemes of TraG* Variants  
  Cell pellets from 500mL LB were resuspended with IMAC Loading Buffer (20mM Tris 
pH 7.5, 200mM NaCl, 10% glycerol). Protease inhibitors phenylmethane sulfonyl fluoride 
(PMSF), Benzamidine HCl and Aminocaproic acid were added to final concentrations of 1.25mM, 
5mM and 5mM respectively. Lysis was performed through sonication at 25% amplitude with a 
20s on, 40s off cycle for 10 min; the lysate was then separated from cell debris through 
centrifugation at 25,000 x g for 30 min at 4°C.   
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 Ni2+ IMAC was performed through a XK26 Ni2+-NTA agarose column using an Äkta 
Purifier 10S FPLC (GE Healthcare). The lysate was pumped into the column at 1mL/min and the 
beads were washed with 100 mL of IMAC Loading Buffer with 30mM Imidazole (Imid), and then 
75 mL of IMAC Loading Buffer with 50 mM Imid. 3mL fractions were taken as the protein was 
eluted with 75mL IMAC Loading Buffer with 200mM Imid for TraG*His and 300mM Imid for 
HisTraG*∆ and TraG*∆His. A final elution was performed with 50mL of IMAC with 500mM or 
1M Imid.  
 
2.4.3 Visualization of Proteins using SDS PAGE 
Samples of interest were aliquoted and appropriately diluted to a 15µL volume, then mixed 
with 5 µL of 4 X SDS buffer (160mM Tris pH 6.8, 4.0% SDS, 20% glycerol, 0.0012% 
Bromophenol blue, 20% β-mercaptoethanol). After boiling at 100 °C for 5 min, 10 µL of each 
sample was loaded onto a 12.5% SDS PAGE gel and electrophoresis was performed. The gel was 
stained with Coomassie solution (50% methanol, 10% glacial acetic acid, 0.1% Coomassie 
Brilliant Blue R250) to visualize protein bands.  
 
2.4.4 Desalting and Quantification of TraG* 
 Fractions from the affinity purification with high quantities of HisTraG* relative to 
impurities were pooled and dialyzed using a 30kDa MWCO centrifugal concentrator column 
(Corning, Millipore) at 5,000 x g at 4°C into 10mM HEPES pH 7.0, 10% glycerol. The protein 
was concentrated to 5mL and then added to a 26 10 HiPrep desalting column (GE) using the Akta 
FPLC with 10mM HEPES pH 7.0, 10% glycerol.  
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The properly exchanged TraG* sample was quantified by Bicinchoninic Acid Assay 
(BCA) using the protocol described on the Pierce™ BCA Protein Assay Kit (Thermo Scientific). 
12.5 µL volumes of various dilutions of the protein sample were mixed with 237.5 µL of the 
working reagent and loaded on a 96 well plate (Sarstedt). After incubation at 37°C for 30 minutes 
the OD562 nm of each sample was determined using the Synergy H4 Hybrid plate reader. After 
protein concentration was determined the HisTraG* sample was loaded onto a 30kDa concentrator 
column and centrifuged to a final volume determined to bring the protein to a concentration of 30 
mg/mL. This concentration would then be confirmed by comparing samples with predicted masses 
of TraG* to samples of BSA with known protein concentration using SDS PAGE (Section 2.4.3). 
The protein was aliquoted, flash frozen with liquid N2, and stored at -80°C. 
 
2.5 Screening and Optimization of Crystallisation conditions of TraG*   
2.5.1 Screening of Crystallisation conditions 
TraG* protein samples were loaded in a variety of concentrations as 0.75 µL amounts to 
the sitting drop wells of a 96 well plate from Axygen. 90 µL of a screening buffer was added to 
the reservoir well, and 0.75 µL of that reservoir solution was mixed with the protein solution drop 
in the corresponding sitting well. This was performed using the buffers from the MCSG -1, -2, -3, 
and -4 kits from Anatrace, as well as PUREPEG and TOP 96 from Anatrace and the JCSG+ screen 
from Qiagen. These plates were sealed to allow vapour diffusion to occur and were kept in a place 
that experiences little vibration at both 4°C and 19°C. Results were checked periodically under a 
stage microscope with a birefringent lens.  
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 Conditions that were determined to produce TraG* crystals were optimized through 
altering pH of the buffer, salt concentration, precipitant content, protein content, temperature and 
drop sizes in 24 well hanging drop plates. Typically, the plate was set up with 1 mL of mother 
liquor in the reservoir, with 1 µL of this solution placed on a plastic coverslip. Then 1 µL of the 
protein solution was added to the reservoir solution droplet and the coverslip was placed onto the 
corresponding reservoir such that the drop was hanging above and diffused with the reservoir due 
to effective sealing of the coverslip using high vacuum grease.  
 Diffraction screening of crystals was performed on a Rigaku MicroMax-007 HF rotating 
anode X-ray generator with a Saturn944+ charge coupled device detector. Potential TraG* crystals 
were looped with appropriately sized microloops (Mitegen), added to a cryogenic solution which 
consisted of conditions mimicking that of the reservoir but with a discrete addition of either 
glycerol, ethylene glycol, or an increased amount of the same precipitant used in the reservoir. The 
crystal was flash frozen in liquid N2 and mounted on the system where diffraction screening was 
performed for 10 seconds of X-ray exposure with 4 images collected at 60.0mm crystal-to-detector 
distance with angles from 0°-2° and 70°-72°.   
 
2.5.2 Thermofluor Assay  
 To quantify the beneficial properties of buffers and salts that seemed to aid the stability of 
TraG* mutants in vapour diffusion experiments, thermofluor experiments were performed. 
Thermofluor, or differential scanning fluorimetry, involves the use of a fluorescent hydrophobic 
probe to determine the optimal solvent-protein interactions using the melting temperature (Tm) of 
the protein as an indicator of stability (Ericsson et al., 2006; Lavinder et al., 2009; Phillips and de 
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la Peña, 2011; Seabrook and Newman, 2013). A protein in a specific buffer and salt condition is 
heated from 25°C to 99°C in a gradient fashion while fluorescence absorption is measured. As the 
temperature is increased the protein begins to unfold and hydrophobic sidechains of its residues 
allow for the hydrophobic probe to bind, causing an increase in the fluorescent signal. 
Fluorescence then decreases again as proteins begin to denature and aggregate. The Tm as dictated 
by the point at which the fluorescent signal is increasing at its highest rate, is indicative of a set of 
buffer conditions that aid in maintaining protein homogeneity, solubility and folding stability; the 
parameters most suitable for crystallisation of a protein would be those which provide the highest 
melting temperature with a well-defined melting curve shape. 
SYPRO Orange dye was the probe used for thermofluor experiments in this thesis, and it 
was prepared through serial dilution from a 5000X commercial stock (Life, ThermoFisher) to a 
final concentration of 10X in the buffers of interest, with 1mg/mL of TraG* (purified with 0% 
glycerol) in a total of 50µL. Fluorescence output was set to 470nm and detected at 610nm, with a 
gain of 5, and the samples were heated from 25°C to 99°C at a ramp rate of 1°C/min. The scheme 
used was similar to that shown in (Seabrook and Newman, 2013); a total of 14 buffers were tested 
at 50mM concentration with either 50mM NaCl or 200mM NaCl, and each condition was 
performed in triplicate, with a lysozyme positive control in 1xPBS, dye-only negative control and 
a protein-only negative control in every experiment. Further optimization was performed with the 
buffer conditions that promoted the highest melting temperature, wherein 8 common salts used in 
crystallography replaced NaCl. 
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2.6 Analysis of TraG* Structural Properties  
2.6.1 Circular Dichroism  
 Circular dichroism (CD) is a widely used and well-developed technique for the 
determination of protein secondary structure (Micsonai et al., 2015; Provencher and Glöckner, 
1981). The technique relies upon the differential absorption of left- and right-hand circular 
polarized light. In this case, the electric field of a photon has a circularly rotational direction 
relative to the propagation direction of the photon, where the photon vector remains constant in 
magnitude (Greenfield, 2007; Kelly et al., 2005). When these photons pass through an asymmetric 
(chiral) molecule, the speed, absorbance and the wavelengths differ depending on the direction of 
their polarization. As the sum of the vectors for the right- and left- handed polarized light forms 
an ellipse, the change in ellipticity (measured as ∆ε) of a substance as a function of the wavelength 
of incident light is reported in performing CD experiments, even though the change in absorbance 
of the differentially polarized light is what is measured in CD spectrometer.    
 The ∆ε of TraG* mutants were measured by CD spectroscopy at 2μM over wavelengths 
190-260nm. To normalize the CD spectra of the proteins the spectrum of the solvent, 10mM 
HEPES pH 7.0, 10% glycerol, was subtracted from the experimental spectra. All spectra were 
obtained through a continuous scan performed at 100μm/min with ∆ε measurements every 0.1nm, 
with an accumulation factor of 8. Urea denaturation experiments were performed to provide an 
indication of protein stability when comparing TraG* with and without the putative IDR, as 
denaturing studies are common for determining the relative stability of protein mutants (Glover et 
al., 2016; Griko et al., 2001; Matsuo et al., 2007). TraG* variants were added to solutions with 
different urea concentrations in 10mM HEPES pH 7.0, 10% glycerol such that the final 
concentration of protein was 2μM. Samples were incubated at 25°C for 1 hour and measured on 
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the CD spectrometer. Initially urea concentrations of 0.5, 1, 2, 3, 4, 5, and 6M to determine the 
approximate range for protein denaturation, which was narrowed to 3‒4M. Then concentrations of 
3.2, 3.4, 3.6 and 3.8 M were tested.  Spectra measurements were performed with the same scanning 
protocol as stated above, and all results were normalized to their respective solvent conditions. 
Deconvolution of all CD data was performed using BeStSeL, an algorithm for protein fold 
recognition and secondary structural determination using input CD spectra, unique in its ability to 
distinguish parallel from antiparallel β-sheets (Micsonai et al., 2015).  
       
2.6.2 Global HDX MS 
A vital technique for the determination of protein structure and dynamics is HDX MS. 
2H2O (D2O) is used to provide an indication for the solvent-exposure of residues in a protein chain 
(Oganesyan et al., 2018). The exchange of the amide hydrogen is highly dependent on the higher 
order structure of the protein, therefore subtle perturbations in solvation affect the exchange rate 
(Balasubramaniam and Komives, 2013; Beveridge et al., 2013; Oganesyan et al., 2018). As well, 
at neutral pH the peptide backbone protons are exchanged at a rate amenable to measurement by 
MS. As a change in the mass-to-charge ratio (m/z) of the molecule over time can be effectively 
measured, the overall dynamics of a protein can be determined based on the rate of deuteration. In 
HDX MS techniques, an acid is used to quench the deuterium exchange reaction, followed by 
enzyme digestion to fragment the macromolecule into peptides allowing for a residue-by-residue 
analysis of solvent exposure, thus providing insight on protein structure (Oganesyan et al., 2018; 
Wang et al., 2002; Zhang and Smith, 1993). In global HDX MS the protein is left intact as a way 
to monitor the overall changes in protein structure and stability; this technique shows the sum of 
exchange kinetics for the individual backbone amides over the entire protein (Houde et al., 2009; 
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Oganesyan et al., 2018). HDX MS requires proteins to enter the spectrometer in gas phase as an 
ion; electrospray ionization (ESI) is a soft ionization method that allows for evaporation of the 
solvent such that molecules in solution are sent into the spectrometer as intact ions in individual 
nanodroplets (Katta and Chait, 1991; Oganesyan et al., 2018).  
In the global HDX scheme performed in this thesis, D2O mixing was performed in the ESI 
capillary; differential deuteration times were obtained by pulling the protein-dispensing capillary 
a measurable distance through an outer capillary into which D2O is pumped, providing discrete 
deuteration time-points. Protein samples were prepared for MS analysis through a Zeba spin 
desalting column (Thermo Fisher) following the manufacturer’s protocol to ensure removal of 
small molecule contaminants and to buffer exchange the protein into 50mM NH4CH3COO pH 6.8, 
MS grade. Native MS analysis was performed on TraG* and TraG*∆ with 5μM protein flowing at 
a rate of 8μL/min. A series of deuteration time points were collected for the native folds of TraG* 
and TraG*∆ to confirm the presence of a putative N-terminal IDR. 0, 1, 2, 5, 10, 20, 50 and 100mm 
time points were collected with 30μM protein flowing at a rate of 4μL/min, and D2O at 16 μL/min. 
Fully deuterated spectra were obtained through a 1:5 mixing of the proteins with D2O to a final 
protein concentration of 5μM, incubated at 25°C for 30 minutes and then electrosprayed at 
8μL/min. In these experiments capillary voltage was set to 3.5 kV, the sampling cone was 150.0 
and the extraction cone was 7.0, with source temperature 120°C, desolvation 250°C, cone gas flow 
30.0L/hr, nanoflow gas pressure at 3 bar, desolvation gas flow at 450L/hr, the trap and transfer 
collision energy was 15.0 and 10.0 respectively, the trap gas flow was 3.0 mL/min and the source 
gas flow was 11.0mL/min. Backing pressure was raised to 3.9 millibar (mBar) to accommodate 
ESI MS of a protein larger than 50kDa (Wilm, 2011).   
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CHAPTER 3.0 ‒ RESULTS AND DISCUSSION  
3.1 Software Mediated TraG Structural Predictions 
The full length TraG sequence was entered into the protein homology/analogy recognition 
engine (Phyre2), resulting in sequences with poor homology to TraG (Kelley et al., 2015). As with 
most structural predictors, Phyre2 uses sequence homology to compare an entered primary 
sequence to those of proteins with solved structures in the protein databank (PDB). A subunit of 
the vacuolar proton ATPase from Thermus thermophilus solved by cryo-electron microscopy 
displayed the highest template coverage at 27%, with a confidence value of 91% and identity of 
7% (Figure 3.1A) (Schep et al., 2016). The modeled residues corresponded to residues S657-K912 
of TraG. This protein was only recognized when the full length TraG sequence was used for the 
query, when TraG* is entered the highest template covered was 3% corresponding to residues 
S751-V766 of the protein with a confidence of 7.3% and identity of 25%. As well, the secondary 
structure analysis of TraG* by Phyre2 revealed 56% of the protein sequence is predicted to be α-
helical, 5% showed a potential for forming β-strands (with low confidence), but overall 56% is 
unstructured (Figure 3.1B). Failure to detect matches for significant regions of a protein sequence 
entered into structural predictors is typically caused by a lack of a sufficient number and diversity 
of homologous sequences to the query, indicating the presence of a novel fold not present in the 
current structural database (Kelley et al., 2015; Zhang, 2009). As mentioned in section 1.6.2., there 
are few homologous proteins to TraG, the regions that are predicted to be disordered may be 
unrecognized as they are part of a novel fold.  
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Figure 3.1: A) A predictive model for residues 657-912 of TraG (residues 205-461 in TraG*) 
from Phyre2 as shown in Pymol (PDB: 5GAS) (Kelley et al., 2015)(Schrödinger, 2015). This 
model is based off of the structure predicted to be most analogous to TraG; the vacuolar ATPase 
a subunit from the archaea T. thermophilus, a structure solved by cryogenic electron microscopy 
to 6.4Å (Schep et al., 2016). The N-terminal residues of this model are magnified to show the 
conformation of a portion of the TraG region expected to be involved in the plasmid specificity of 
Eex; an extended α helix may be responsible for interactions with TraS. B) The secondary structure 
prediction of TraG* as calculated by Phyre2 (Kelley et al., 2015). The legend shows the confidence 
level in the mapping of each amino acid to a secondary structure conformation. TraG* is predicted 
to be mainly alpha helical, with a high level of disorder. The region Phyre2 recognized as 
analogous for predictive modeling is boxed from residues 205-461.  
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3.1.1 PSP Software Analysis of TraGF Reveals a Putative IDR  
 Sequence analyses of full length TraGF using a variety of popular structural prediction 
software provided variable results in their structural predictions of TraG*. Many of the algorithms 
described in Section 2.2 provided predictions similar to those seen in Figure 3.2A from the 
software IUPred2A and ANCHOR 2A. IUPred2A bases its structural disorder predictions on 
theoretical redox state and potential for binding to global protein partners, while ANCHOR 2A 
uses homology to known protein structures to recognize disordered regions with the potential for 
becoming ordered upon binding (Dosztányi et al., 2009; Mészáros et al., 2018). The two programs 
similarly recognized ordered secondary structures in the membrane-bound residues M1-A440, 
however predictions identifying disordered regions of TraG* showed contradiction. In many 
instances, the primary sequences that result in peak values which cross the predictive threshold for 
IDRs in one software show a trough in the other software, and vice versa. As mentioned in Section 
3.1 failure of multiple predictive software highly dependent on analogy to achieve consensus 
regarding the secondary structure of a region is likely indicative of a lack of structural data for 
homologous proteins (Kelley et al., 2015; Zhang, 2009). As TraG*F is a synthetic construct that is 
not normally expressed without the N-terminal domain, the successful expression and purification 
of TraG*His and untagged TraG* in previous studies provides evidence of a stable fold inherent 
in the protein (Ergodan, 2016). A synthetic protein with many closely interspersed highly 
disordered regions would likely aggregate, as most native IDPs evolved to prevent self-aggregation 
and perform their in vivo function (Uversky et al., 2008).  
 The novel phase separation predictor (PSP) software for predicting phase separating IDRs 
with long range pi-pi contacts proved more insightful in determining which regions of TraG are 
putative IDRs and can be targeted for mutation or deletion (Vernon et al., 2018). The region from 
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residues 447-498 was predicted to cause phase separation in the protein, with 27 of these residues 
surpassing the score threshold of 4.0 thus providing TraG with an overall score of 4.06. When the 
sequence for TraG* is entered into the PSP (Figure 3.2C), the resultant P score is 2.53 as the 
influence of the N-terminal region for increasing phase separation propensity is lowered as the 
algorithm predicts an expected level of disorder in terminal residues. However, the 48 N-terminal 
residues approach the threshold score for the PSP to predict the described region as phase 
separating, thus the N-terminus may provide a degree of disorder sufficient to prevent good 
crystallization. When the sequence of TraG*∆ is input in the PSP (Figure 3.2C) the P score is 
lowered to 1.37, a substantial reduction for the deletion of 45 amino acids. This provided ample 
evidence to proceed with the cloning of TraG*∆ mutants.  
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Figure 3.2: Software mediated identification of IDRs in TraG from the F plasmid. A) IUPred2A 
and ANCHOR 2A algorithms were used in tandem to analyze the TraG primary sequence and 
produce the graph, shown as red and blue lines respectively (Dosztányi et al., 2009; Mészáros et 
al., 2018). B) the resultant 2D heat map and graph produced by entering the TraG sequence into 
the PSP (Vernon et al., 2018). The only region predicted to be an IDR based on phase separation 
is therefore the putative linker from residues P447-Q498, as it is the only region that surpasses the 
designated confidence threshold. TraG* shows a lower predicted capacity for phase separation as 
seen in C) due to the algorithm’s treatment of N-terminal residues. As a large region with high 
predicted disorder in its N-terminus results in difficulty in crystallisation, the truncation mutant 
TraG*∆ was conceived. D) the PSP result for the TraG*∆ sequence, predicting low overall phase 
separating propensity.   
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3.2 Successful Cloning of TraG* Constructs  
 DNA extraction of the necessary starting products for cloning was successful, with pET28a 
empty vector seen as pure and at the expected size of 5369bp (Figure 3.3A). pET28aG* was 
observably larger than the expected mass of 6656 bp due to differences in DNA topology, where 
the lowest MW band is supercoiled DNA, and increasing weights are further relaxed 
conformations.  
The amplicons replicated from pET28aG* for the cloning of plasmids encoding for N-
terminally His6-tagged TraG* (HisTraG*), N-terminally His6-tagged TraG*∆ (HisTraG*∆) and C-
terminally His6-tagged TraG*∆ (TraG*∆His) are seen in Figure 3.3B. The primers described in 
Table 2.1 were successful in the amplification of the desired gene products and provided the 
expected sizes of 1464 bp, 1329bp and 1326bp respectively. After purification, restriction enzyme 
digestion, ligation and transformation steps described in Section 2.3.3, successful colony growth 
was achieved in all 1:5 and 1:7 ligation experiments; the DH5α colonies from the transformed 1:7 
ligation product were used for further experimentation due to their optimal colony number and 
size. Dideoxy sequencing (BioBasic) after purification of the plasmids from O/N cultures showed 
proper insertion of the genes as well as the correct genetic code. Heat shock transformation into 
BL21 competent cells was performed successfully; the plasmid constructs mini-prepped from O/N 
BL21 cultures and restriction enzyme double digests of these constructs are shown in Figure 3.3C 
and displays the correct size of every plasmid and gene insertion. Table 1.1 lists the plasmid 
constructs, their abbreviations, and the abbreviation of the proteins they express.  
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Figure 3.3: A) Plasmid constructs used for the cloning of traG* displayed on a 1.2% agarose gel 
after electrophoresis. pET28a was the target vector for insertion of traG* as amplified from 
pET28aG*, which has full length traG* inserted in its MCS. B) The amplicons coding for HisG*, 
HisG*∆, and G*∆His, produced through PCR of pET28aG*. C) Successfully cloned plasmid 
constructs mini-prepped from BL21. N: undigested plasmid, D: single digest by restriction enzyme 
BamHI, DD: restriction enzyme double digest (BamHI and HindIII for N-terminally tagged 
products, NcoI and HindIII for C-terminally tagged products), M1: GeneRuler 1kb DNA Ladder 
(#R0491 ThermoFisher), M2: 100bp DNA Ladder H3 RTU (#DM003-R500 GeneDireX).   
 
3.3 Expression and Purification of TraG* Constructs 
The optimized 18°C O/N TraG*His expression scheme was seen to induce transcription 
and translation of TraG*His to a higher extent compared to expression at 37°C for 4 hours (results 
not shown). Chromatograms and SDS PAGE images of optimized purification schemes for the 
TraG* constructs are shown in Figures 3.3 & 3.4. TraG*His was seen to be isolated with slightly 
lower overall purity and yield in comparison to HisTraG*. A gradient purification was performed 
for HisTraG* as the purity and yields were ameliorated in this scheme compared to step elution 
schemes.  
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Figure 3.4: Optimized Ni2+ IMAC purification schemes of TraG* variants presented on a 
chromatogram and a 12.5% SDS PAGE gel, purified with a XK26 Ni2+-NTA agarose GE column 
using an Äkta Purifier 10S FPLC. The purification schemes were performed using 20mM Tris pH 
7.5, 200mM NaCl, 10% glycerol as the sample running buffer and eluted with 20mM Tris pH 7.5, 
200mM NaCl, 10% glycerol, 1M Imid. A) Purification scheme of TraG*His, where PL: lysate 
from culture prior to induction, Lys: lysate after O/N 18°C expression, W: from 0-150mL, E1: 
peak at 245mL, E2: peak at 260mL, E3: end of the peak at 275mL, E4: 500mM Imid elution at 
330mL, EW1: pooled 240-275mL, EW2: pooled 500mM Imid from 320-350mL. B) Gradient 
purification scheme for HisTraG*, where labelling is the same as above except P: cell debris pellet, 
W2: 50-100mL, E1: 120mL (127mM Imid), E2: 135mL (256mM Imid), E3: edge of peak at 
145mL (323mM Imid) E4: 155mL (436mM Imid), G*His: 1μg of purified TraG*His. In all figures 
shown M: unstained protein marker (ThermoFisher #26610). 
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HisTraG* and TraG*His both show two bands copurifying at the approximate size of the 
proteins of interest (Figure 3.4) (see Appendix A). The lower MW abundant protein in TraG*His 
seems to be of similar quantity to that of the higher MW species. In the HisTraG* purification the 
relative amount of the higher MW protein is abundant in comparison to the lower MW band. As 
well, an impurity of the same size appears to be highly present in the wash fractions for HisTraG*. 
It was predicted that the higher MW band is the full-length protein and the lower MW band is a 
common degradation product, possibly from the removal of the putative IDR in the N-terminus. 
This conclusion is supported by the increased purity of the N-terminally His-tagged protein, as N-
terminal cleavage products would not have the opportunity to bind the Ni-IMAC column unlike 
the C-terminally His-tagged variant which would allow for the purification of products with N-
terminal degradation. 
TraG*∆His was not seen to be expressed, while HisTraG*∆ purified optimally in 
comparison to the other constructs (Figure 3.5A and B). Furthering the above argument is the 
evident purity of the HisTraG*∆; no degradation products are seen. The lack of expression in 
TraG*∆His might be due to the requirement for some residues to serve as a N-terminus; without 
them the region may be excessively solvent exposed such that the formation of its proper secondary 
structure is prevented, causing instability and degradation during expression. The comparison 
between 1μg of HisTraG*∆, 0.5μg of TraG*His and 1μg of BSA show accuracy in BCA 
quantitation (Figure 3.5B). 
The purification schemes were proven to be optimal for all proteins except TraG*∆His 
through observation of the lanes displaying lysate, washes and elution fractions (Figures 3.4 and 
3.5). In lysate samples an abundance of the expected 54.2 kDa protein in comparison to the protein 
contaminants is seen. As well the washes show low levels of the desired proteins with high 
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amounts of impurities, such that the chromatograms show a nearly baselined UV280nm before the 
peak shown to be abundant TraG* is eluted. In many cases, a UV280nm peak is seen in the 
chromatograms at the 1M Imid elution despite no protein being eluted. This is likely absorbance 
caused by imidazole, which can absorb light at 280nm due to the conjugated pi system of the 
molecule.   
 
Figure 3.5: Optimized Ni2+ IMAC purification schemes of TraG*∆ variants presented on a 
chromatogram and a 12.5% SDS PAGE gel, purified with a XK26 Ni2+-NTA agarose GE column 
using an Äkta Purifier 10S FPLC. The purification schemes were performed using 20mM Tris pH 
7.5, 200mM NaCl, 10% glycerol as the sample running buffer and eluted with 20mM Tris pH 7.5, 
200mM NaCl, 10% glycerol, 1M Imid. A) Purification scheme of TraG*∆His where Lys: lysate 
after O/N 18°C expression, P: cell debris pellet, W1: 0-25mL, W2: 100-125mL, E1: fraction of 
peak at 173mL, E2: fraction of peak at 177mL, EW1:180mL, EW2: 190mL, EW3: peak at 230mL 
B) holds a similar labeling scheme for the purification of HisTraG*∆, however E1: 165mL, E2: 
175mL, EP: pooled 160-180mL, HisG*∆: 1μg of HisTraG*∆, HisG*: 0.5μg of HisTraG*, EW: 
220mL, BSA: 1μg of BSA. In all figures shown M: unstained protein marker (ThermoFisher 
#26610).  
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3.4 Thermofluor Analyses of TraG*His and HisTraG*∆ Reveal Differences in Protein 
Stability 
The resultant melting curves from performing thermofluor analyses of TraG*His in various 
buffer conditions exhibited notable trends. On average, conditions with 200mM NaCl provided a 
lower observed Tm than when buffers had 50mM NaCl (Figure 3.6A). As well variability was high 
for conditions below pH 6.0 as seen by the large error bars representing standard deviation between 
triplicate data points. The buffers that provided TraG*His optimal Tm values were 50mM Citrate 
pH 6.0 and 50mM NaCH3COO pH 5.2 at approximately 54°C (Figure 3.6A & B). These values 
are proximal to the protein’s predicted pI of 5.61 (Appendix A). The melting curve provided when 
TraG*His was in 50mM citrate pH 6.0 was markedly improved in terms of the optimal shape in 
comparison to that of 50mM NaCH3COO pH 5.2 (Figure 3.6B). Some conditions with pHs higher 
than pH 6.0 had a poor or indistinguishable increase in fluorescence throughout the melting curve, 
such as the data seen for 50mM MES pH 6.0 (Figure 3.6A &B). This indicates TraG*His was 
unstable in this buffer condition and was partially or completely misfolded and/or aggregated prior 
to the gradient temperature increase; the resultant melting curve starts with higher fluorescence 
and decreases as the protein continues to aggregate and exclude SYPRO. A notable trend seen in 
most successful melting curves was a higher baseline RFU in most conditions for HisTraG*∆ 
relative to TraG*His, which is likely an artifact of difficulties in normalizing thermofluor data. 
Trends in the thermofluor analysis of HisTraG*∆ are contrary in some respects to those of 
TraG*His.  Buffers with a pH lower than 5.2 do not confer a notable HisTraG*∆ melting curve, 
however many buffers that did not produce a melting curve for TraG*His due to high pH values 
were seen to do so with HisTraG*∆, albeit the Tm values were lower than average (Figure 3.6A). 
As seen in Figure 3.6B, 50mM NaCH3COO pH 5.2 may have provided a higher Tm to HisTraG*∆ 
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than TraG*His, however the melting curve of HisTraG*∆ is poor with numerous abnormalities 
prior to the main peak at 54.37°C. Similar to TraG*His, buffers with 50mM NaCl concentration 
were seen to provide a more favourable melting curve for HisTraG*∆ unfolding in comparison to 
buffers with 200mM NaCl. Lower NaCl concentration appeared to maintain folding of both 
proteins as temperature was increased. This may be caused by increased heat capacity of the 
solvent when less ionic strength is present, or from higher ionicity affecting intermolecular 
interactions by masking charges in TraG*, or both phenomena contribute to the result. As the 
RotorGene Q measures the internal temperature of the system rather than the temperature of the 
buffers themselves it is possible the buffers with higher salt content absorbed more kinetic energy 
at the same temperatures and therefore caused the proteins to unfold at lower temperatures. As 
well, increasing salt concentrations may create ‘salting out’ effects; as ionicity is increased salt 
ions can mask the inter- and intra- molecular ionic interactions that prevent protein unfolding at 
increased temperatures (Dumetz et al., 2007).   
In comparing the thermofluor data from HisTraG*∆ and TraG*His it is evident that 
HisTraG*∆ has higher overall stability (Figure 3.6A). Without a buffer, HisTraG*∆ in ddH2O 
shows a melting curve with a Tm 4.8°C higher than TraG*His in ddH2O, and the HisTraG*∆ 
melting curve is superior to many of those in which TraG*His is in a buffer system (Figure 3.6A 
& B). The optimal buffers for both proteins were shown to have a pH near the predicted pI of the 
protein; the pI of HisTraG*∆ is 5.89 (Appendix A). A peculiar result was the unfavourability of 
TraG*His for 50mM MES pH 6.0, which was the buffer which gave the highest Tm for HisTraG*∆. 
As TraG*His also had its highest Tm in a pH 6.0 Citrate buffer, it is interesting that MES 
destabilizes TraG*His at the same pH.  
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   Further optimization of TraG*His buffer conditions was performed through the alteration 
of the pHs for the three buffers that gave the highest Tm values; 50mM NaCH3COO pH 4.0, 50mM 
NaCH3COO pH 5.2, and 50mM citrate pH 6.0. All buffers had pHs changed above and below in 
0.2, 0.4, and 0.8 -unit intervals, centered around the previously used pH; the most favourable 
melting curve shape found was for 50mM NaCH3COO pH 5.6 (Figure 3.7). Citrate pH 6.0 has a 
higher Tm values, however as vapour diffusion experiments showed NaCH3COO pH 5.6 provided 
spherulite formation (as described in Section 3.5), it was deemed as the optimal buffer for 
attempting further optimization experiments with various salts common in crystallography.  
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Figure 3.6: Thermofluor analysis of TraG*His shown in blue and HisTraG*∆ shown in red. A) the 
melting temperatures (Tm) in triplicate, as well as means with standard deviations, of both proteins 
as they were incubated in each buffer condition shown on the x-axis. Each buffer is at a 
concentration of 50mM (except ddH2O and PBS), where 1 represents the addition of 50mM NaCl 
in the buffer and 2 includes 200mM NaCl. Instances where no data points appear for a buffer 
condition specify no clear melting temperature was observed in the melting curve, indicating the 
destabilizing nature of the buffer on TraG* folding. B) Graphs displaying fluorescence output as 
a function of temperature is shown for a sample of the buffer conditions, in which all buffers listed 
feature 50mM NaCl. NaAc represents NaCH3COO. Mean melting temperatures with standard 
deviations for these conditions are shown in the table.   
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 In analyzing the results of the thermofluor analyses for the identification of salts 
efficient in stabilizing TraG*His and HisTraG*∆ some similarities are seen (Figure 3.7). The salts 
that best stabilize both proteins based on favourable melting curve shape and Tm are those with 
dianions, with sulfate as the ideal anion. As well Mg2+ seemed to have a favourable effect on both 
proteins, providing optimal shapes to melting curves whenever present. NiCl2 and NaF provided 
observably poor melting curves; despite providing high Tm values the lack of fluorescent signal 
increase was deemed destabilizing. The optimal salts in these buffer conditions were 50mM 
(NH4)2SO4 for TraG* His and 50mM KCl for HisTraG*∆.    
 
 
 
 
 
 
 
Figure 3.7: Optimization of buffer conditions for TraG* stability through screening of 9 salts 
common in crystallography. 50mM NaCH3COO pH 5.6 was used in A) for TraG*His as it was 
determined to be the optimal buffer, while experiments using HisTraG*∆ shown in B) were 
performed in 50mM MES pH 6.0. Averages of each fluorescence reading at every temperature 
point were taken for three trials to produce the above graphs, and the corresponding mean melting 
temperatures with standard deviations are listed in the above table.    
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3.5 Crystallisation of TraG*His   
 Previous crystallisation screening experiments of untagged TraG* showed the protein 
forms microcrystals in conditions from pH 6.5-8.0 with 200-250mM (NH4)2SO4 and 18-25% PEG 
3350 (w/v). Purified TraG*His was screened in 96 well sitting drop vapour diffusion plates with 
commercial screens in concentrations of 2, 5, 10, 20, 30 and 40 mg/mL. As no optimizable crystal 
hits were observed, 24 well hanging drop screening was performed with conditions similar to those 
suitable for the crystallisation of untagged TraG*. Spherulites were seen when optimizing 
conditions with 100mM NaCH3COO, and the largest ones were seen in panel 1 of Figure 3.8B. As 
shown in the other panels, successive rounds of microseeding (µseeding) from these spherulites 
and subsequent crystals grown therein changed spherulite morphology. µseeding was performed 
through isolation of a crystal in 1µL of reservoir by use of a microloop, addition of the 1µL to 
99µL of reservoir solution in a microfuge tube with a seed bead, followed by 2 minutes of 
vortexing prior to serial dilution and addition into droplets. A diffraction quality 3-dimensional 
crystal was never obtained; all spherulites shown grew mainly about two axes and had little depth, 
forming disk- and crater- like structures. The spherulites grown in panel 5 were imaged prior to 
isolation through looping into a separate droplet which was pipetted into a microfuge tube, 
denatured and identified as protein by SDS PAGE (Figure 3.8A). Comparing the profile of the 
TraG*His spherulite to a 1μg sample of fresh TraG*His and denatured TraG*His demonstrates 
that common degradation products of TraG*His rather than full length protein are responsible for 
producing these spherulites. As well, a 1μg sample of purified HisTraG* after a single freeze-thaw 
cycle shows new degradation bands not initially present after IMAC purification, corresponding 
to the same approximate size as the protein species seen in lane in which the spherulite sample was 
added. However, when HisTraG*∆ is purified in the same manner no degradation bands are seen. 
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This further supports the hypothesis for the presence of an IDR in the N-terminus of TraG*, as the 
removal of this region prevents any of the phenomena seen when the N-terminus is present. No 
diffraction quality crystals of HisTraG* or HisTraG*∆ have been observed at this moment, 
however crystal screening of these variants was not as thorough.   
Attempts to diffract the spherulites produced from TraG*His vapour diffusion experiments 
were unsuccessful; the only diffraction which produced observable spots was that seen in Figure 
3.9C. All other diffraction attempts produced ice rings with no observable spots, similar to the 
diffraction image seen in Figure 3.9F. Ice rings were more common in conditions in which low 
precipitant concentration was used in the reservoir solution, as less precipitant could be effectively 
used to cryo-protect these crystals without causing crystal degradation prior to flash-freezing. 
Addition of glycerol to 10% (v/v) dissolved all spherulites attempted for diffraction, however some 
spherulites were further cryo-protected by the addition of ethylene glycol to a final concentration 
of 10% (v/v). The spherulite that produced some spots from diffraction was shown to be crystalline 
through its birefringent properties (Figure 3.9A and B), however as the reflections are well spaced 
in the resulting diffraction pattern this spherulites was likely composed of a small molecule 
packing into a small unit cell (Figure 3.9C). As many spherulites similar to those seen in Figure 
3.9D and E produced no diffraction, the composition of these spherulites cannot be confirmed.   
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Figure 3.8: A) Purified TraG* constructs post desalting, concentration and quantification as 
shown on a 12.5% SDS PAGE. The image shows HisG*∆: 1μg of HisTraG*∆, HisG*: 1μg of 
HisTraG*, TraG*His samples include a 0.5μg sample, a denatured sample (left at 4°C for 3 weeks), 
and a 1μg sample. Xtal represents the crystals seen in panel 5 which were isolated into a 1μL 
droplet containing a 1:1 mix of the reservoir solution and ddH2O using a microloop, then pipetted 
into a microfuge tube and prepared for loading onto the gel as described in Section 2.3. M: 
unstained protein marker (ThermoFisher #26610). B) TraG*His crystals from hanging drop vapour 
diffusion experiments. Spherulites were produced from successive rounds of µseeding and 
optimization, in which either 1µL of 40mg/mL TraG*His was mixed with 1µL of reservoir (Image 
1), or 1.2µL of 40mg/mL (Image 2&5) or 30mg/mL (Image 3&4) TraG*His with 0.8µL reservoir 
and 0.4µL of a seed stock from the previous image’s crystal (Images 2-4).  
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Figure 3.9: X-Ray diffraction of spherulites produced in a TraG*His vapour diffusion experiment. 
A) a hanging drop from the mixing of 40mg/mL TraG*His in a 1μL:1μL ratio with 350mM 
MgSO4, 0.1M NaCH3COO pH5.6, and 22% PEG3350 (w/v), taken after 21 days of vapour 
diffusion at 19°C. A zoomed in spherulite from this droplet is shown in B), with a cross-polarizing 
filter on to display the crystalline nature of the spherulite through its bireferingent properties. This 
image was taken after 35 days of vapour diffusion. On the same day the spherulite focused on in 
B) was looped with a 100μm microloop, soaked for 2 minutes into the same buffer condition with 
25% PEG3350 (w/v), flash frozen and diffracted. C) displays the ice rings and a diffraction pattern 
not consistent with a protein crystal from the 3rd image of 4 collected from diffraction screening. 
D) a hanging drop from the mixing of 50mg/mL TraG*His in a 1μL:1μL ratio with 350mM 
MgSO4, 0.1M NaCH3COO pH5.6, and 20% PEG3350 (w/v), taken after 25 days of vapour 
diffusion at 19°C. A zoomed in spherulite from this droplet is shown in E), taken after 16 days of 
vapour diffusion. On day 27 the spherulite focused on in E) was looped with a 100μm microloop, 
soaked for 2 minutes into the same buffer condition as the resevoir but with 23% PEG3350 (w/v), 
flash frozen and diffracted. F) displays the ice rings from the 1st image of 4 collected from 
diffraction screening.   
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3.6 CD of TraG* Variants Provides Evidence of an N-terminal IDR  
 Findings from performing CD on HisTraG* and HisTraG*∆ are aligned with the 
hypothesized presence of an IDR in the N-terminus of TraG*. As seen in Figure 3.10, the CD 
spectra of each variant appears to be mainly α-helical based on the characteristic negative ∆ε peaks 
at 222nm and 208nm (Greenfield, 2007). This confirms that many of the predictive software were 
incorrectly labeling many regions of the protein as intrinsically disordered due to the lack of 
homologous protein sequences with solved structures. Deconvolution by BeStSel shows 
differences in the extent to which the two variants fold into canonical α helices (Figure 3.10, Table 
3.2) (Micsonai et al., 2015). The model providing the best fit for HisTraG* showed that 76.1% of 
the protein was predicted to be α-helical, albeit 21.1% of helices are of a bent or imperfect topology 
(Figure 3.10A). Turns were of low abundance in the overall structure of the protein at 4.8%, and 
the remaining 19.1% of the protein was deemed as ‘other,’ which represents unstructured regions 
undetectable by CD. BeStSel also groups uncommon helical forms with lowered propensity to 
affect the resultant ∆ε into the ‘other’ section, such as 310 and π helices, (Geetha, 1996; Micsonai 
et al., 2015; Wilman et al., 2014). The spectrum of HisTraG*∆, which appears to have better defined 
peaks at 222 and 208nm, is predicted to have 0% ‘other’ character and is an all α-helical protein, 
with 5.3% of the protein predicted as representative of turns between the α-helices. This provides 
a strong indication that the 45 residues removed from the protein are intrinsically disordered; the 
N-terminal IDR in TraG* could be causing distortions in the remaining protein fold based on the 
high relative change in the predicted percentage of assigned conformations.  
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Figure 3.10: The CD spectra of A) HisTraG* and B) HisTraG*∆ as displayed by BeStSel 
(Micsonai et al., 2015).  Experiments were performed at a protein concentration of 2μM, where 
the buffer system was 10mM HEPES pH 7.0, 10% glycerol when measured in the 
spectrophotometer, and the resultant data was normalized by the blank buffer. Fitting spectra of 
the TraG* variants (experimental data shown in red) to those of proteins with known structure 
(shown in blue) allowed for the prediction of the secondary structure composition of each protein, 
as seen in the pie charts beside each spectrum. BeStSel uses pie charts to provide a visual 
representation of the predicted secondary structure content of each protein based on the CD 
spectra.  Distorted helices represent regions in which the α helix geometry is imperfect resulting 
in helices more closely resembling a 310 helix, while regions referred to as ‘Other’ include 310 and 
π helices, but also loops that may not change the direction of polarized UV light and are therefore 
undetectable by CD (Geetha, 1996; Micsonai et al., 2015; Wilman et al., 2014).  
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Table 3.2: Secondary structure of HisTraG* and HisTraG*∆ as predicted by analysis of CD spectra 
by BeStSel (Micsonai et al., 2015). 
Protein Regular α-helix Distorted α-helix Turns Other 
HisTraG* 55.0% 21.1% 4.8% 19.1% 
HisTraG*∆ 94.7% 0% 5.3% 0% 
 
 Urea denaturation studies were performed to support the conclusion surmised from the 
thermofluor data that TraG*∆ has higher stability than TraG*. Spectra and tables displaying 
predicted secondary structure topology by BeStSel are displayed in Figure 3.11, and from 
comparing spectra of HisTraG* to HisTraG*∆ it is evident that the presence of residues A1-A44 
destabilizes TraG*. HisTraG* displayed higher susceptibility to unfolding based on the direct 
decrement of ∆ε at 222 and 208nm as the urea concentration was increased. The secondary 
structure of HisTraG*∆ remained relatively intact until incubation with 4.0M urea, while the 
secondary structure of HisTraG* was partially unfolded at 1.0M urea based on the topology 
analysis from 260-200nm by BeStSel. As data from 207-200nm is subject to variability due to the 
UV absorption properties of urea, the topology analyses may be inaccurate despite correction using 
a buffer blank.  
 Further investigation of the unfolding processes of TraG* variants was performed through 
the analysis of a finer range of urea concentrations from 3.0-4.0M (Figure 3.12). HisTraG* is 
shown to have a substantial reduction in secondary structure character between 3.0M - 3.2M urea 
(Figures 3.12 A and B respectively). The spectra of HisTraG*∆ shows ∆ε values are approaching 
0 but the spectrum retains the characteristic shape of an all α-helical protein until 3.6M urea (Figure 
3.12 D). At 4.0M urea the CD spectra of the TraG* proteins overlap, indicating the same degree 
of unfolding has been reached for both protein samples. This data aids in concluding that 
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differences in ∆ε throughout the CD experiments are due to distinct secondary structures of the 
respective protein samples and not due to variability in concentrations, as the molarity of a chiral 
molecule affects the extent to which molar ellipticity is changed during a CD experiment. Due to 
the presence of spectra overlap at a point in which the two proteins are not entirely unfolded (as 
seen by the further increase of ∆ε at 5.0M urea in Figure 3.11), this assures the accuracy of CD 
results in dictating the secondary structure of the variants, and therefore TraG* exhibits a stabilized 
secondary structure by the removal of the putative N-terminal IDR.  
  
Figure 3.11: Urea denaturation of A) HisTraG* and B) HisTraG*∆ as measured by CD 
spectroscopy. All experiments were performed with a final protein concentration of 2μM and were 
incubated in the respective concentrations of urea (shown in the figure legends) for 1 hour at 25°C 
prior to UV measurement. The resultant data was normalized by the buffer. Molar ellipticity 
measurements were obtained every 0.1nm from 260-190nm, however due to inconsistencies in 
UV absorption of urea at wavelengths between 207-190nm only data from 260-208nm is shown. 
Data from 260-200nm was entered into BeStSel for deconvolution, and the resultant analyses were 
tabulated as percentages (Micsonai et al., 2015). 
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Figure 3.12: Denaturation experiments sampling refined urea concentrations between 3-4M using 
the proteins HisTraG* and HisTraG*∆. Proteins at concentrations of 2μM were incubated at 25°C 
for 1hr in A) 3.0M B) 3.2M C) 3.4M D) 3.6M E) 3.8M F) 4.0M urea prior to CD measurement. 
The resultant data was normalized by the blank buffer. Molar ellipticity measurements were taken 
every 0.1nm from 260-190nm, however due to inconsistencies in UV absorption of urea at 
wavelengths between 207-190nm only data from 260-208nm is shown. 
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3.7 Analysis of TraG* by Global HDX MS Confirms Dynamicity in its N-terminal Residues  
 The goal of global HDX MS experiments was to compare relative deuteration rates of the 
TraG* variants independent of their inherent mass such that their dynamics could be elucidated, 
thus providing information regarding the solvent exposure of the truncated region. ESI-MS 
analysis of HisTraG* and HisTraG*∆ shows that the charge states of highest abundance in both 
proteins were +15, +14, and +13, and were the peaks used for all analyses in comparative 
experiments. The protein masses observed include 54,447.91 ±0.32 Da and 51,740.90 ± 0.45 Da 
respectively (Figure 3.13), while the actual masses are expected to be 56262.90 and 51573.94 Da 
(Appendix A). These masses were calculated from m/z values of the prominent peaks using 
ESIprot (Winkler, 2010). The increase of approximately 160 Da in HisTraG*∆ is likely due to H2O 
and other solvent components interacting with the protein. The decrease in mass for HisTraG* is 
contrary to experimental evidence as no degradation products were seen when samples were 
analyzed by SDS PAGE. The ESIprot algorithm calculates a mass around 58.5 kDa if the m/z 
values of the right-most distribution of the peaks are entered, which causes all of the charge states 
to shift by +1 (Winkler, 2010). It is possible that masses have been incorrectly predicted by the 
utilized primary sequence analysis tool ProtParam, or that ionization is causing a truncation of 
approximately 1815 Da (~17 aa) at the higher charge states due to the higher energy input 
(Gasteiger et al., 2005). The first 17 residues of the protein are from the His6 affinity tag of the 
pET28a vector and are likely to be cleaved due to a thrombin recognition site at this location, 
indicating the possibility for the resultant cleavage product to be the highly recognized species by 
ESI MS.  
Other notable features in the spectrum of HisTraG* not appearing in the spectrum of 
HisTraG*∆ are the extra distributions of small shoulders immediately to the left of the +16 and 
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+15 charge state peaks, which correspond to a 60Da difference between the peaks, indicating the 
presence of a common adduct to the protein. As the most favourable buffer condition for TraG*His 
was determined to be in NaCH3COO it is likely that this mass increase corresponds to the acetate 
anion from NH4CH3COO. As it is not seen in the spectrum of HisTraG*∆ it is possible that the N-
terminal IDR is responsible for its binding, and thus provides the protein with enhanced stability. 
Small peaks intermittent in the abundant charge state distributions are likely due to a low 
percentage of ESI droplets that happen to contain two molecules of HisTraG*, rather than being 
caused by a low proportion of protein dimerization; a common occurrence when backing pressure 
of the Synapt G1 system is raised to 3.9 mBar to accommodate ESI MS of a protein larger than 
50kDa (Wilm, 2011). Another notable aspect of the mass spectra is the increased presence in a 
gaussian distribution of high charge states (+25-+22) seen in HisTraG*∆ but not HisTraG*. This 
is indicative of a small population of unfolded or denatured proteins, which is unexpected as the 
deletion mutant was designed to be more stable (Donnelly et al., 2019).  
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Figure 3.13: ESI-MS analysis of native folds for A) HisTraG* and B) HisTraG*∆. Proteins in 
50mM NH4CH3COO pH 6.8 were flowed through the ESI capillary at concentrations of 5μM at 
8μL/min. Monomers for both proteins are seen in the 3200-4300 m/z range with prominent charge 
states of +16 to +13 for TraG* and +15 to +13 for TraG*∆. These provided average molecular 
weights of 54,447.91 ±0.32 Da and 51,740.90 ±0.45 Da respectively, calculated using ESIprot 
(Winkler, 2010). 
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Figure 3.14: Global HDX-MS analysis of HisTraG* and HisTraG*∆. Measurements were taken 
at 0, 1, 2, 5, 10, 20, 50, and 100mm time points with 30μM protein inserted at a rate of 4μL/min, 
and D2O at 16 μL/min. A fully deuterated spectrum was taken as well to provide a 100% 
deuteration reference point to which the other time point measurements were compared. The 
corresponding graphs were fit to a one phase decay distribution. The mass spectra to their right 
with corresponding colour schemes show undeuterated spectra in colour and the fully deuterated 
spectra in black.     
  
Global HDX MS analysis of the TraG* variants at different deuteration time points further 
supported the hypothesis of an N-terminal IDR and provided evidence that its removal further 
stabilized the protein. Deuterium uptake was calculated as a percentage based on comparisons to 
the fully deuterated samples; fully deuterated proteins had a calculated uptake of 928.5 ±4.35 and 
969.1 ±16.9 deuterium atoms (average of the +15‒+13 charge states) for HisTraG* and 
HisTraG*∆, respectively. This calculation accounts for an effect on the perceived deuteration 
caused by comparisons made between proteins that differ in overall protein size. The amount of 
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overall deuterium uptake was higher for the truncated protein however, indicating differences in 
TraG* dynamics upon removal of the N-terminal IDR. 
Upon the comparison of deuteration rates fit to a one-phase decay using GraphPad, 
deuterium uptake was significantly higher in HisTraG* in comparison to HisTraG*∆ (Figure 3.14). 
However, the overall rate of deuteration appear to be similar based on the shape of the limited 
growth curves (1-e-kt), indicating TraG* and the TraG*∆ perform similar dynamic movements. 
After 40 ms of D2O mixing prior to ESI, deuteration was observed to be ~50% of the experimental 
maximum for HisTraG*, while HisTraG*∆ demonstrates ~23% of maximum deuteration. As 
momentary exposure to D2O caused a comparatively rapid accumulation of deuterium onto 
HisTraG* relative to HisTraG*∆, the truncated region must be highly dynamic. 
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CHAPTER 4 ‒ CONCLUSIONS AND FUTURE WORK 
4.1 The N-terminal Dynamic Region of TraG* and its Potential Role for Protein Function 
TraG is a multifunctional protein in the F-T4SS. It is composed of a membrane-bound N-
terminal domain required for pilus generation and a C-terminal periplasmic domain (TraG*) 
required for Eex and Mps. TraG* therefore requires plasticity in its structure to facilitate these 
different functions that are thought to require numerous PPIs. Based on the findings presented in 
this thesis it can be stated that the N-terminal region of TraG* is highly dynamic and its presence 
destabilizes the protein, as confirmed through comparisons of thermofluor and CD results to the 
results from the truncation mutant. These characteristics are not sufficient in identifying the region 
as an IDR; IDRs shorter than 50 residues are not uncommon, however they typically serve a 
functional purpose in the native protein (Van Der Lee et al., 2014). As this region in TraG has not 
been shown to be intrinsically disordered, the region cannot be classified as an IDR. However the 
TraG* constructs explored in this report provided evidence that the region from A452-A496 is 
prone to degradation and is highly solvated. The region likely serves as a flexible linker in the full-
length protein, however when expressed separately from the N-terminal membrane bound portion 
this region of TraG* displays higher dynamicity due to its expression as a synthetic construct.      
As the only deletion mutant tested was from the truncation of 45 amino acids, the size of 
the disordered region has not been defined in full, however this finding has many implications. 
Many structural predictive software such as Phyre2, IUPred2A, ANCHOR 2A, and many more, 
improperly identified secondary structure properties of TraG*; overestimating disorder content to 
be present in approximately 50% of the protein (Figure 3.1B and 3.2A). The CD analysis of TraG* 
ensured the protein is not largely disordered; some regions are instead predicted to feature distorted 
helices, with 19.1% being disordered (Section 3.7). This confirms that these programs were falsely 
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assigning regions of TraG* as disordered due to their inability to identify homologs with known 
structures, enforcing the postulation regarding the novelty of this protein structure. The 
identification of a highly dynamic region by the PSP software was successful; therefore other 
popular algorithms should be modified to include disorder predictions based on long range pi-pi 
contact frequencies to improve their accuracy (Section 3.1).  
Confirming the presence of a dynamic N-terminus in TraG* elucidates the basis for many 
of the phenomena observed in purification and crystallisation of TraG* and TraG*∆. HisTraG* 
purified with less degradation products than TraG*His, as is logical if the N-terminus is prone to 
auto-cleavage (Section 3.3). It is possible that TraG*∆His did not express properly due to a lack of 
protein stability when no residues are present before T497; perhaps the formation of an α-helix 
vital to the native fold of the structure is disrupted by increased solvent exposure when this region 
is N-terminal, thus lowering the cellular longevity of the protein. A similar phenomenon has been 
seen before in sperm whale myoglobin, however deletions were performed with knowledge of the 
protein structure (Ribeiro and Ramos, 2005).  
The mechanism behind spherulite formation in crystallisation studies of TraG*His can be 
explained by the presence of a highly dynamic N-terminus of 45 amino acids. SDS PAGE of 
spherulites showed the main component of these crystals is from degradation products, which 
corroborates a basis for the duration prior to visualizable spherulite growth (Section 3.5). It is 
likely the time elapsed allows for sufficient degradation of TraG* such that the resultant N-
terminally truncated TraG* is of sufficient abundancy to be self-concentrated into a nucleation 
point for a crystal. The presence of full length TraG* would disrupt proper crystal formation, 
leading to the observed spherulites. Intermittent stacking of full-length TraG* in crystals of the 
protein with truncations has the potential to disrupt a proper crystal lattice from forming as it would 
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alter the shape of the respective unit cells. The incessant motion of the N-terminal region could 
prevent proper packing or disrupt a vital crystal contact and therefore prevent crystal growth in 
one axis of the lattice. This would explain the 2D disk-like shape of the spherulites. X-Ray 
diffraction of spherulites commonly yielded no discernable spots (Figure 3.9F), however some 
spherulites provided diffraction patterns akin to a small molecule or salt crystal based on the 
distantly interspersed spots indicating a well-packed, small unit cell (Figure 3.9C). These 
spherulites may have been an anomaly, as other spherulites have proven to be proteinaceous based 
on an SDS PAGE (Figure 3.6) but did not produce a diffraction pattern (Figure 3.9F). 
The formation of proteinaceous spherulites in conditions that were deemed as favourable 
by thermofluor assays is promising for the technique. The formation of crystalline objects in the 
presence of sulfates and the magnesium cation, also shown to be stabilizing by thermofluor assays, 
may indicate their presence in forming important ionic intramolecular interactions for protein 
function or intermolecular interactions for crystal contacts (Sections 3.4 and 3.5). As well the 
increased Tm of conditions where buffer pH was approximate to the respective predicted pI of the 
proteins is interesting, as crystal trials are often suggested to be started with the pH of the mother 
liquor equal or proximal to the pI of the protein (Kantardjieff and Rupp, 2004; Kirkwood et al., 
2015). Maintaining protein charge at net neutral is predicted to aid in the formation of 
intermolecular interactions, which is why increased stability and crystallisation propensity is seen 
with these conditions.    
Results from global HDX MS show that the presence of the highly dynamic region in 
TraG* causes increased deuterium uptake, and therefore is highly solvated relative to TraG*∆ 
(Section 3.7).  However, more deuterium uptake was observed in the HisTraG*∆ relative to that of 
HisTraG*. This is counterintuitive based on the larger size of TraG* and contrary the hypothesis 
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that the truncation mutant is more stable. There was also evidence that some unfolded species were 
present in the native mass spectra of TraG*∆ which could be the cause of the increased overall 
deuterium uptake of the fully deuterated TraG*∆ sample (Figure 3.13 B). The observed unfolded 
species could be a result of a fraction of the protein denaturing during the final desalting and buffer 
exchange; perhaps it does not remain stable in NH4CH3COO. TraG* may be stabilized by the 
acetate ion as indicated in thermofluor and MS experiments, while the truncation mutant does not 
appear to share this characteristic. The overall shape of the deuterium exchange rate curves for 
both proteins look similar however, indicating the loss of the N-terminal region does not drastically 
change the conformational states achievable by the protein, or the rate at which these folding states 
change.       
The discussed N-terminal region of the protein is implicated in connecting the membrane-
bound portion of TraG and periplasmic TraG*; it would be congruent with known moieties in 
structural biology that this region would serve as a highly dynamic linker region between these 
two domains that display different functionalities. It is logical to assume this region of the protein 
requires a high degree of flexibility to mediate the variety of interactions TraG* performs. In 
related systems, these two domains are commonly separate proteins as discussed in Section 1.6.2. 
Therefore, it is possible this region is merely a linker and does not contain interacting domains, 
making it non-essential in the protein’s structural solution. In vivo experiments such as conjugative 
mating assays could not be performed to support this theory as TraG* is not functional when 
expressed on its own (Audette et al., 2007).  
4.2 Future Work  
 This study suggests the presence of a highly dynamic region in residues A452‒A496 of 
TraGF, however the boundaries for the size of the region have not been fully identified as only one 
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deletion mutant was tested. To further the analysis, different mutants could be conceived with 
additions or deletions of the current TraG*∆ sequence to define the region that serves as a putative 
linker. The same experiments described in this report could be performed, however to further 
support the identification of a dynamic region, protein phase separation experiments should be 
considered as this region was predicted to be a phase separating IDR (Section 3.1.1)(Nott et al., 
2015).  
 Alternatively, solving the structure of TraG*∆ will dictate whether the dynamic region has 
been completely or partially removed as determined through analysing the density at the N-
terminus. Crystallisation of TraG*∆ is vital in solving the structure though X-Ray diffraction to 
provide an understanding of the protein’s hypothesized function and indicate whether the N-
terminus is an essential component of the periplasmic domain. Therefore, further crystal trials of 
HisTraG*∆ will be performed. As the protein is predicted to be a novel structure as there currently 
exists no solved structure of high homology, molecular replacement will not be possible (Dimaio 
et al., 2011). Multiple isomorphous replacement (MIR) and single wavelength anomalous 
diffraction (SAD) phasing must be performed through either heavy atom soaking of a TraG*∆ 
crystal or the expression of a selenomethionine derivative protein and subsequent crystallisation 
and diffraction (Hendrickson et al., 1990; Leahy et al., 1994).       
Some unexpected results were seen throughout this report and must be confirmed as either 
anomalies or as results bearing a biochemical or physical basis. The lack of expression seen in 
TraG*∆His was an interesting result and requires further investigation (Section 3.3). It will be 
confirmed that additional residues must be added to the N-terminus through the utilization of 
different C-terminal tags to the same protein. Constructs of N-terminally GST-tagged variant of 
TraG* and TraG*∆ have been made; a C-terminal tagged variant of both should be made and 
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expressed. If the same phenomenon occurs, it will confirm the inability for the protein to properly 
fold if no region precedes T497 of TraG*. As well, cleavage of the N-terminal His6 tag from 
HisTraG*∆ is an additional experiment to test the requirement of additional residues prior to T497. 
However, there will be an additional 17 residues from the remaining pET28a tag prior to the start 
of the TraG*∆ sequence, which may alter the result. Alternatively, a plasmid containing a C-
terminally His6-tagged truncation mutant from the highly homologous TraG*R100 could be 
constructed and its expression could be tested in the same manner. 
Other unexpected results included some of the non-congruent data in the thermofluor 
assays, such as TraG* being destabilized by MES pH 6.0 (Section 3.4). Further thermofluor studies 
must be performed with different buffer and salt concentrations, pHs, and entirely new buffer and 
salt combinations in order to properly assess solvent interactions with TraG* and protein variants. 
CD deconvolution by BeStSel did not provide logical secondary structure predictions for spectra 
provided from urea denaturation experiments (Section 3.6). This was likely due to abnormalities 
in the spectra from 207-190nm from the UV absorption of urea, however these are vital regions 
for structural information to be gleaned from CD. A different method should be performed such 
as heat denaturation or use of a different chemical denaturant such as guanidine hydrochloride 
(Matsuo et al., 2007; Rashid et al., 2005). 
 Discrepancies between the predicted size of HisTraG* and its observed size by ESI MS 
were theorized to be caused by a truncation of the 17 aa tag during ionization (Section 3.7). To 
confirm this, purified HisTraG* will have its His6 tag removed using thrombin cleavage, untagged 
TraG* will be purified by collecting it in the flow through of a Ni2+-IMAC purification, the size 
of tagged and untagged compared by SDS PAGE, and the sample will be analysed through ESI 
MS. Global HDX MS results effectuated speculation of differences in TraG* mutant stability when 
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NH4CH3COO is used as a buffer. Further replicates of the native MS and global HDX MS will be 
performed with TraG*∆ to confirm the presence of an unfolded population that may cause an 
increase in the overall deuterium uptake of this protein. As well, local HDX MS with time resolved 
ESI (TRESI) can be used to deuterate the protein, quench with acid at various time point, and then 
use trypsin digestion to generate peptide fragments (Konermann et al., 2011; Oganesyan et al., 
2018). This will allow for a refined analysis of the residue-by-residue solvent exposure of the 
protein and will allow for an accurate definition of the N-terminal dynamic region, as well as 
answering other questions on the protein’s dynamics. The global HDX MS experiments showed 
the rate of deuterium uptake is similar between TraG* and TraG*∆, indicating similarities in their 
achievable folds. Using small angle X-ray scattering will confirm changes in accessible 
conformational modes with the N-terminus deleted, as common folding states can be detected as 
low-resolution electron density models (Wen et al., 2014). These experiments would aid in 
assessing the viability of further experiments with TraG*∆, as maintenance of the native fold is 
essential in assuring structural solution of this mutant produces an accurate depiction of the region 
as it would be when attached to full length TraG is in the T4SS complex.   
To properly identify the role TraG* plays in the F pilus, its predicted interacting partners 
must be confirmed to interact. Pulldowns with GST-tagged TraS and TraN peptide fragments on 
the stationary phase could be used to identify binding of TraG*, as passing the protein through the 
column would identify which regions have strong affinity for TraG*. Confirmation of these protein 
interactions would be vital and would allow for the elucidation of regions responsible for 
performing the complex interaction within the F pilus superstructure. As well, if TraG*∆ abolishes 
or exhibits lowered affinity for the observed TraG* interactions it will provide an indication for 
whether the putative linker performs any important interactions or is merely a bridge between the 
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two domains of the protein. The structural solution resulting from diffraction of TraG*∆ co-crystals 
with TraS peptides could be achieved to better support the conclusions made in these studies.  
The goal in studying the F‒T4SS is to develop a universal functional model of the 
conjugative system such that novel antibiotics could be developed that target all or most 
pathogenic gram-negative bacterial species, as the F pilus is designated as the canonical gram-
negative conjugative secretion system. TraG*R100 can be studied to see if its structure is similar to 
that of TraG*F. If the same linker is present then it is likely that the entry exclusion system of all 
F-like pili with homologous proteins function in a similar manner and allow for plasmid specificity 
as discussed in previous work (Audette et al., 2007). It is vital to determine whether all F-like pili 
function similarly in order to develop antibiotics that will target a wide array of gram-negative 
MDR pathogens.  
TraG and TraS form the Eex system of the F pilus and are heavily relied upon for 
preventing donor-donor plasmid exchange (Achtman et al., 1980, 1977). As excessive conjugation 
can lead to lethal zygosis it has been theorized that disruption of Eex systems would be detrimental 
to bacterial colony survival (Garcillán-Barcia and de la Cruz, 2008). Development of novel 
antibiotics to disrupt TraG‒TraS interactions and cause ceaseless conjugation or completely 
prohibit conjugation is contingent on the structural knowledge of the system’s protein subunits. 
The identification of a highly dynamic region within TraG advances its structural study and 
provides insight for further experimentation in the objective of a high-resolution structural 
solution.   
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APPENDICES 
Appendix A ‒ Relevant Amino Acid Sequences for Proteins used in this Thesis 
TraG*His  
        10         20         30         40         50         60  
AGSVVDGNYS YGNMQTENVN GFSWSTNSTT SFGQMMYQTG SGATATQTRD GNMVMDASGA  
 
        70         80         90        100        110        120  
MSRLPVGINA TRQIAAAQQE MAREASNRAE SALHGFSSSI ASAWNTLSQF GSNRGSSDSV  
 
       130        140        150        160        170        180  
TGGADSTMSA QDSMMASRMR SAVESYAKAH NISNEQATRE LASRSTNASL GLYGDAYAKG  
 
       190        200        210        220        230        240  
HLGISVLGNG GGVGLQAGAK ASIDGSDLDS HEASSGSRAS HDARHDIDAR ATQDFKEASD  
 
       250        260        270        280        290        300  
YFTSRKVSES GSHTDNNADS RVDQLSAALN SAKQSYDQYT TNMTRSHEYA EMASRTESMS  
 
       310        320        330        340        350        360  
GQMSEDLSQQ FAQYVMKNAP QDVEAILTNT SSPEIAERRR AMAWSFVQEQ VQPGVDNTWR  
 
       370        380        390        400        410        420  
ESRRDIGKGM ESVPSGGGSQ DIIADHQGHQ AIIEQRTQDS NIRNDVKHQV DNMVTEYRGN  
 
       430        440        450        460        470        480  
IGDTQNSIRG EENIVKGQYS ELQNHHKTEA LTQNNKYNEE KLAQERIPGA DSPKELLEKA  
 
       490        500  
KSYQHKEKLA AALEHHHHHH  
 
Number of amino acids: 500 
Molecular weight: 54238.70 Da 
Theoretical pI: 5.61 
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HisTraG*  
        10         20         30         40         50         60  
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSAGSVVD GNYSYGNMQT ENVNGFSWST  
 
        70         80         90        100        110        120  
NSTTSFGQMM YQTGSGATAT QTRDGNMVMD ASGAMSRLPV GINATRQIAA AQQEMAREAS  
 
       130        140        150        160        170        180  
NRAESALHGF SSSIASAWNT LSQFGSNRGS SDSVTGGADS TMSAQDSMMA SRMRSAVESY  
 
       190        200        210        220        230        240  
AKAHNISNEQ ATRELASRST NASLGLYGDA YAKGHLGISV LGNGGGVGLQ AGAKASIDGS  
 
       250        260        270        280        290        300  
DLDSHEASSG SRASHDARHD IDARATQDFK EASDYFTSRK VSESGSHTDN NADSRVDQLS  
 
       310        320        330        340        350        360  
AALNSAKQSY DQYTTNMTRS HEYAEMASRT ESMSGQMSED LSQQFAQYVM KNAPQDVEAI  
 
       370        380        390        400        410        420  
LTNTSSPEIA ERRRAMAWSF VQEQVQPGVD NTWRESRRDI GKGMESVPSG GGSQDIIADH  
 
       430        440        450        460        470        480  
QGHQAIIEQR TQDSNIRNDV KHQVDNMVTE YRGNIGDTQN SIRGEENIVK GQYSELQNHH  
 
       490        500        510        520  
KTEALTQNNK YNEEKLAQER IPGADSPKEL LEKAKSYQHK E  
 
Number of amino acids: 521 
Molecular weight: 56262.90 Da 
Theoretical pI: 5.77 
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TraG*∆His  
        10         20         30         40         50         60  
TQTRDGNMVM DASGAMSRLP VGINATRQIA AAQQEMAREA SNRAESALHG FSSSIASAWN  
 
        70         80         90        100        110        120  
TLSQFGSNRG SSDSVTGGAD STMSAQDSMM ASRMRSAVES YAKAHNISNE QATRELASRS  
 
       130        140        150        160        170        180  
TNASLGLYGD AYAKGHLGIS VLGNGGGVGL QAGAKASIDG SDLDSHEASS GSRASHDARH  
 
       190        200        210        220        230        240  
DIDARATQDF KEASDYFTSR KVSESGSHTD NNADSRVDQL SAALNSAKQS YDQYTTNMTR  
 
       250        260        270        280        290        300  
SHEYAEMASR TESMSGQMSE DLSQQFAQYV MKNAPQDVEA ILTNTSSPEI AERRRAMAWS  
 
       310        320        330        340        350        360  
FVQEQVQPGV DNTWRESRRD IGKGMESVPS GGGSQDIIAD HQGHQAIIEQ RTQDSNIRND  
 
       370        380        390        400        410        420  
VKHQVDNMVT EYRGNIGDTQ NSIRGEENIV KGQYSELQNH HKTEALTQNN KYNEEKLAQE  
 
       430        440        450  
RIPGADSPKE LLEKAKSYQH KEKLAAALEH HHHHH  
 
Number of amino acids: 455 
Molecular weight: 49549.73 Da 
Theoretical pI: 5.72 
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HisTraG*∆  
        10         20         30         40         50         60  
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSTQTRDG NMVMDASGAM SRLPVGINAT  
 
        70         80         90        100        110        120  
RQIAAAQQEM AREASNRAES ALHGFSSSIA SAWNTLSQFG SNRGSSDSVT GGADSTMSAQ  
 
       130        140        150        160        170        180  
DSMMASRMRS AVESYAKAHN ISNEQATREL ASRSTNASLG LYGDAYAKGH LGISVLGNGG  
 
       190        200        210        220        230        240  
GVGLQAGAKA SIDGSDLDSH EASSGSRASH DARHDIDARA TQDFKEASDY FTSRKVSESG  
 
       250        260        270        280        290        300  
SHTDNNADSR VDQLSAALNS AKQSYDQYTT NMTRSHEYAE MASRTESMSG QMSEDLSQQF  
 
       310        320        330        340        350        360  
AQYVMKNAPQ DVEAILTNTS SPEIAERRRA MAWSFVQEQV QPGVDNTWRE SRRDIGKGME  
 
       370        380        390        400        410        420  
SVPSGGGSQD IIADHQGHQA IIEQRTQDSN IRNDVKHQVD NMVTEYRGNI GDTQNSIRGE  
 
       430        440        450        460        470  
ENIVKGQYSE LQNHHKTEAL TQNNKYNEEK LAQERIPGAD SPKELLEKAK SYQHKE 
 
 
Number of amino acids: 476 
Molecular weight: 51573.94 Da 
Theoretical pI: 5.89 
Reference: (Gasteiger et al., 2005)  
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Appendix B ‒ Generation of Competent E. coli Cells 
 Overnight cultures of DH5α cells were prepared in LB broth (37°C, >150rpm).  The 
overnight culture was used to inoculate sterile LB broth in a 1:100 ratio. Incubation was performed 
at 37 °C, >150 rpm until O.D.600 reached the beginning of the logarithmic growth phase (0.4-0.6). 
The cells were incubated on ice for 10 minutes before centrifugation was performed for 10 minutes 
at 2,700 x g, 4 °C. LB was decanted from the cell pellet and the pellet was re-suspended with 1.6 
mL ice cold, filtered and autoclaved 100 mM CaCl2. Cells were then incubated on ice for 30 
minutes before being centrifuged for 10 minutes at 2,700 x g, 4 °C. Again, the supernatant was 
completely removed, and the pellet was re-suspended with 1.6mL 100 mM CaCl2. The cells were 
incubated on ice for 20 minutes to equilibrate. 0.25 mL of ice-cold autoclaved 80% glycerol was 
slowly added to the 1.6mL of cells and mixed gently until homogeneous. The competent cells were 
then stored at -80 °C for up to 6 months. The same procedure was followed for the generation of 
competent BL21 (DE3) cells. 
 
